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ABSTRACT
IDENTIFICATION OF TWO DISTINCT GLUTAMINYL CYCLASE ISOFORMS IN
DROSOPHILA MELANOGASTER
by Amanda Thigpen Parker
August 2008

Sequence analyses revealed two putative glutaminyl cyclase genes in Drosophila
melanogaster with greater than 60% amino acid sequence identity to previously
identified glutaminyl cyclase in humans. Expression, purification, and characterization
of both putative proteins revealed two enzymatically active glutaminyl cyclase enzymes.
Comparison of the Drosophila melanogaster glutaminyl cyclase enzymes to the
published human glutaminyl cyclase revealed the enzymes were very similar. The Km
values obtained were identical to those of human glutaminyl cyclase for three different
substrates tested. However, the Drosophila glutaminyl cyclases demonstrated lower
turnover numbers. Both Drosophila glutaminyl cyclase isoforms were inhibited by
imidazole, imidazole derivatives, and metal chelators. The predicted tertiary structure of
the Drosophila glutaminyl cyclase isoforms revealed a conservation of the overall tertiary
structure and active site amino acids when compared to human glutaminyl cyclase.
Localization studies demonstrated differential location of the two isoforms within
the Drosophila melanogaster embryo. One isoform was expressed at much higher levels
and found within the developing nerve cord suggesting this isoform of the Drosophila
glutaminyl cyclase is important in neuronal development. These glutaminyl cyclase
isoforms join peptidyl-glycine a-amidating monooxygenase and prohormone convertase
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2 as the known bioactive peptide processing enzymes in Drosophila and provide the first
evidence of two distinct glutaminyl cyclase isoforms located within one organism.
Evolutionary studies revealed further links between bacterial aminopeptidases and
the mammalian and insect glutaminyl cyclases. Previous work demonstrated a common
fold and active site between human glutaminyl cyclase and bacterial aminopeptidase.
Slight aminopeptidase activity was observed in the human glutaminyl cyclase and both
glutaminyl cyclase isoforms. It was also determined the glutaminyl cyclases were able to
bind leucine derivatives which are common aminopeptidase substrates. This observation
led to the identification of a new class of competitive inhibitors for glutaminyl cyclases.
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CHAPTER I
LITERATURE REVIEW
Introduction
Hormones, the chemical messengers of the endocrine system, are used for
signaling and regulation in most living organisms. They are responsible for initiating and
regulating many reactions throughout the body, such as hunger and feeding, growth,
sexuality, and development. Hormones are produced within specialized cells termed
endocrine glands and secreted directly into the bloodstream for travel to target cells.
There are four major types of hormones. The steroid family hormones are
produced and travel through plasma membranes by diffusion due to their hydrophobic
nature. Examples include corticoids secreted from the adrenal gland and steroids
secreted from the testes, ovaries, and adrenal glands. Their mechanism of action involves
a receptor-hormone complex that controls transcription and mRNA stability. Amino acid
and fatty acid derivatives are two other classes of hormones that are less common.
Amino acid derivatives include catecholamines and fatty acid derivatives include
prostaglandins and thromboxanes. They are relatively fast acting and rapidly degraded.
The final class of hormones is polypeptide hormones. These hormones though
typically composed of a few amino acids can range up to hundreds of amino acids in size.
Regardless of final mature protein size, all polypeptide hormones are secreted as large
precursors which are subsequently modified. Examples of commonly known peptide
hormones include insulin and glucagon, which are produced in the pancreas and exert an
effect throughout the body by controlling glucose metabolism, and leptin, which is
produced in fat cells, is responsible for regulating body weight, metabolism, and
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reproductive function. Another group of polypeptide hormones, the gonadotropins, are
produced in the pituitary and function to regulate sexual processes.
Peptide hormones require a more complex mechanism of action than other
hormone types. The peptide must interact with a receptor to activate a second messenger
and protein kinase activity. Most commonly a peptide hormone binds the receptor
protein, activating a G-protein. The active G-protein activates adenylyl cyclase leading
to the release of cAMP. The cAMP then initiates a cascade of reactions leading to
activation and inactivation of specific enzymes. This activity demonstrates that a
relatively small amount of hormone can exert a large cascade effect on the target cell.
(Lindberg 1996; Bear 2001)

Post-translational Processing
Secretory Pathway
Many proteins, including various peptide hormones, are produced as inactive
precursors that require the activity of post-translational processing enzymes to achieve
maturity. Post-translational modifications of peptides are believed to occur within the
secretory pathway. In the secretory pathway, shown in figure 1, proteins are synthesized
and modified throughout various types of cell machinery involving the activity of many
different enzymes. Proteins are produced in an immature form, typically as large
precursor polypeptides, at the ribosomes and cotranslationally inserted into the lumen of
the rough endoplasmic reticulum. Once synthesized, the immature proteins are
transported to the Golgi apparatus for proper sorting. Proteins secreted by the regulated
secretory pathway are enclosed into secretory granules for extracellular release of
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concentrated mature peptide under the regulation of external stimulation and control.
Other proteins, under the control of the constitutive secretory pathway, are continually
produced and secreted from the specific cell types regardless of presence or absence of
environmental factors.
During the initial delivery of the newly synthesized polypeptide into the lumen of
the rER, proteins are folded into proper tertiary structure, disulfide bonds are formed to
aid in maintaining the proper tertiary structure, and N-linked glycosylation occurs if the
proper conserved sequences are present and accessible. Further post-translational
maturation occurs during transit from the rER through the Golgi apparatus including
modification of N-linked sugars, O-linked glycosylation, tyrosine sulfation, Nacetylation, and serine phosphorylation. Final modifications such as exoproteolysis,
endoproteolysis, amidation, and pyroglutamate (pGlu) formation occur in the transport of
partially mature polypeptides to the secretory granules. (Lindberg 1996; Beinfeld 19P8;
Canaffl999)
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Figure 1: Secretory pathway. Diagram demonstrating the biosynthetic secretory
pathway in which peptide hormones are synthesized, modified, and transported into
vesicles for further proteolytic processing. (Lindberg 1996)

Secretory Pathway Enzymes
Prohormone Convertase
Four major enzymes are responsible for some of the important peptide hormone
modifications that occur within the secretory pathway. Proteolytic maturation by
exoproteolysis and endoproteolysis is catalyzed by two major families of enzymes.
Prohormone convertases (PCs) are responsible for endoproteolytic cleavage of large
precusor sequences. There are multiple forms of PCs with varying expression levels in
different cells types. Prohormone convertase 2 (PC2) appears to be the most catalytically
efficient and most widely distributed PC in neural and endocrine tissues and cell lines.
Therefore, PC2 is believed to be a major prohormone convertase required for peptide
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hormone and neuropeptide maturation. (Beinfeld 1998) PC2 is calcium activated and
prefers an acidic pH for optimal activity both of which are properties of the secretory
granule environment. (Lindberg 1996) PC2, which is produced as an immature propolypeptide, is coexpressed with a neuroendocrine secretory protein termed 7B2. In the
late stages of the rER following folding of the proPC2, 7B2 binds the proPC2 facilitating
the transport of proPC2 complex into the secretory pathway. Once in the secretory
granules 7B2 is released and proPC2 is converted to active PC2 due to the low pH, high
calcium environment. (Canaff 1999; Zhou 1999)
PC2 deficiencies have been linked to various disease states. One study linked the
lack of PC2 or the chaperone 7B2 has been linked to optic atrophy, insulin-dependent
diabetes mellitus, vasopressin-sensitive diabetes, and neurosensory hearing loss. In this
study, authors observed subjects could not properly process vasopressin and insulin
resulting in major defects of various neurological processes. (Gabreels 1998)
Deficiencies in PCI genes have been linked to monogenic obesity due to improper
enzyme function. (Arner 2000) A possible link between PCs and specific tumor types
was suggested due to a high frequency of PCs in tumors. (Kimura 2000) Other studies
have provided possible links between Alzheimer's and prion diseases. PC2 was shown to
be essential for complete processing of amyloid polypeptide. (Wang 2001) Similar
studies provided similar results for amyloid peptide but also established the requirement
of PC for processing of prion disease peptides. (Checler 2002)
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Carboxypeptidase
Further proteolytic reactions are catalyzed by another group termed
carboxypeptidases (CPs). These enzymes are responsible for removing terminal dibasic
residues. Similar to PCs, there are multiple carboxypeptidase enzymes. The most
important CP in peptide hormone maturation is carboxypeptidase E, CPE, which removes
C-terminal basic amino acids. Carboxypeptidase E is found in secretory granules,
activated by Zn2+, and has an acidic pH optimum. (Canaff 1999)
Mice homozygous for Ser2 Pro mutation of the CPE allele demonstrated marked
hyperproinsulinemia and developed late onset obesity. Research demonstrated the
homozygous mutants lacked CPE enzyme activity along with decreased levels of
processed insulin, neurotensin, and melanin-concentration hormone. These results
demonstrate that abnormal maturation of neuropeptides and peptide hormones affect
overall body regulation, specifically the peptide hormones involved in hunger and
feeding. (Rovere 1996) Similar studies demonstrated a link between mutations of CPE
to late onset obesity in double mutant mice. (Berman 2001)

Peptidyl glycine a-amidating monooxygenase
Terminal modifications include amidation and pyroglutamate formation.
Peptidylglycine a-amidating monooxygenase (PAM) removes C-terminal glycine
residues to produce a C-terminal amide, the most common terminal modification.
Amidation occurs on over 50% of all neuropeptides. Amidation is a two-step reaction
catalyzed by the enzymes a-hydroxylating monooxygenase (PHM) and peptidyl aamidating lyase (PAL). These two enzymes together form the catalytic unit known as
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PAM. (Lindberg 1996) In the reaction first PHM catalyzes hydroxylation of the glycine
in a reaction that requires copper, ascorbate, which serves as a nitrogen donor, and
molecular oxygen, which serves as an oxidizing agent. Second, PAL, a zinc dependent
enzyme, converts the intermediate into the amidated peptide resulting in the release of
glyoxylate. (Steveson 2003)
Similar to other processing enzymes, deficiencies in PAM have been linked to
various disease states. An increase in amidation activity in human plasma was observed
in patients with hypothyroidism and thyroid carcinoma demonstrating a link between
proper PAM activity and thyroid health. (Wand 1985) Examination of the relationship
between amidation and amyloid peptide neurotoxicity revealed amidation of amyloid
peptide reduced the activity due to a decrease in amyloid peptide aggregation but did not
alter the neurotoxicity. (Forloni 1997) Microarray studies demonstrated an upregulation
of PAM expression in metastic breast cancer. (Hao 2004)

Glutaminyl Cyclase
The final enzyme glutaminyl cyclase (QC) removes N-terminal Gin residues to
produce a pyroglutamic acid residue. The formation of this residue is believed to serve a
protective function on the N-terminus. Figure 2 demonstrates the action of these
enzymes on the maturation of thyrotropin releasing hormone, a peptide hormone
requiring the secretory pathway for maturity. (Pohl 1991)

8

TRH Processing
1

TRH

TRH

Prohormone convertases

TRH

•

TRH

TRH

255

Endoproteolytic cleavage

Prepro-TRH (KRQHPGKR)
Carboxypeptidase

J1L

Aminopeptidase

™

Removal of Dibasic Residues

Pro-TRH (QHPG)
r AM, QC

JIL

Alpha amidation and pGIu formation

TRH (pGlu-His-Pro-NH2)
Figure 2: Thyrotropin-releasing hormone maturation. Post-translational
maturation of thyrotropin-releasing hormone (TRH) from rat brain requires
endoproteolytic cleavage of a large precursor by prohormone convertase followed by
exoproteolytic cleavage by carboxypeptidases and aminopeptidases. Final maturation
requires both PAM and QC for terminal modification. Complete processing results in 5
mature, functional copies of TRH.

Pyro glutamic Acid and Common pGIu Peptides
The common N-terminal secretory pathway modification produces pyroglutamic
acid (pGIu), also known as 5-oxo-L-proline or pyrrolidone carboxylic acid. This
modified amino acid can be found on the N-terminus of many neuropeptides and peptide
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hormones in many species of plants, insects, and mammals. The pGlu modification is
formed due to the activity of the enzyme glutaminyl cyclase during protein biosynthesis
or as an intermediate in amino aid metabolic and transport pathways. Non-enzymatic
cyclization of glutamine has been observed though the level is much slower. The
presence of the N-terminal pGlu residue has been shown to be important in receptor
binding and/or protection from proteolytic digestion. The table below demonstrates the
peptide sequence of many peptides from different species that contain the N-terminal
pyroglutamic acid residue.

Table 1: Common pGlu Peptides.
Peptide Name

Species

Thyrotropin-releasing hormone
Gonadotropin-releasing hormone
Gastrin I

Human
Human
Human

Fertilization promoting peptide
Morphogenetic neuropeptides
Neuropeptide
Stem cell inhibitory peptide
Growth-hormone releasing factor

Human
Human
Human
Human
Human

Growth-inhibiting pentapeptide
Caerulin-like peptide
Adipokinetic hormone
Leucosulfakinin-II

Mouse
Amphibian
Insect
Insect

Corazonin
Chitinase

Insect
Plant

Peptide Sequence
pGlu-His-Pro-NH2
pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2
pGlu-Gly-Pro-Trp-Leu-(Glu)5-Ala-Tyr-Gly-Trp-MetAsp-Phe-NH2
pGlu-Glu-Pro-NH2
pGlu-Pro-Pro-Gly-Gly-Ser-Lys-Val-Ile-Leu-Phe
pGlu-Pro-Pro-Gly
pGlu-Glu-Asp-Cys-Lys
pGlu-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-ArgAla-Arg-Ala-Arg-Leu-NH2
pGlu-Glu-Asp-Ser-Gly-OH
pGlu-Asp-Tyr-(HS03)-Lys-Gly-Trp-Met-Asp-Phe-NH2
pGlu-Lys-Thr-Phe-Ser-Pro-Asp-Trp-NH2
pGlu-Ser-Asp-Asp-Tyr-(S03H)-Gly-His-Met-Arg-PheNH2
pGlu-Thr-Phe-Gln-Tyr-Ser-Arg-Gly-Trp-Thr-Asn-NH2
pGlu-Cys-Glu-Thr-Thr-Ile-Tyr-Cys-Cys-Ser-Gln-His...

Evidence of QC involvement in various disease states
Evidence of the involvement of QC, one of the important post-translational
processing enzymes, has been observed in many different disease states including
Alzheimer's disease, cancer, fat, and bone mineral density. Initial studies with P-amyloid
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peptide (AP), the peptide commonly found in senile plaques, revealed the dominant form
of the peptide contained a modified glutamate residue at the amino-terminal third
position. The modified Ap peptide was believed to be more likely to be deposited into
senile plaques than the unmodified peptide due to its increase in hydrophobicity. (Saido
1995) Further studies confirmed the pyroglutamate modification of the glutamate residue
in over 50% of A(3 accumulated in senile plaques. This study also revealed the aminoterminal modification greatly influenced toxicity, interaction with cell membranes, and
degradation in Ap peptides. (Russo 2002) These observations led to the investigation of
the role of QC in senile plaque formation. Human QC expressed in both yeast and
bacterial expression systems and papaya QC were tested with an A|3 peptide containing a
glutamate residue. Experimental evidence demonstrated the glutamate was converted to
pyroglutamate at a pH of 6.0 in the presence of both enzymes. This provided the first
evidence for the conversion of glutamate instead of glutamine. (Schilling 2004) To
further investigate the possible involvement of QC in the formation of pGlu-modified Ap
peptides researchers tested the effect of QC inhibitors in vivo. Using mammalian cells
expressing the unmodified AP peptide, QC activity was investigated using a HPLC
method. Once the conversion of the AP peptides was confirmed, various QC inhibitors
were added. These inhibitors decreased the amount of AP peptide conversion. (Cynis
2006)
Various studies have revealed a possible link between cancer and QC. An early
study revealed that pGlu modifications were essential for chemotaxis and protection from
degradation in human monocyte chemotactic protein (MCP-2). (Coillie 1998) This
study suggested a possible role of pGlu modifications and QC in cancer progression.
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Microarray studies revealed that a ten-fold increase in QC expression occurs in
melanocytes when compared to normal cells suggesting a possible role of QC in these
cell types. (Curto 2002) Gene expression profiling of breast cancer cells, P-catenin
expressing cancer cells, and thyroid cancer cells also revealed a similar upregulation of
QC expression. (Lee 2003; Chamorro 2005; Jarzab 2005)
A link between QC and fat regulatory genes was established by a genome-wide
analysis of C. elegans fat regulatory genes. This study used RNAi to disrupt the
expression of 16,757 genes necessary for normal fat storage. Disruption of QC
expression resulted in a decrease in the amount of fat stored in high fat mutants
suggesting QC is involved in the storage of fat in C. elegans. (Ashrafi 2003)
Bone mineral density (BMD) is a key signature of osteoporosis. Studies of adult
women with low radial BMD have demonstrated variations in the QC gene of the
pituitary play a potential pathogenic role in osteoporosis. Using regression analyses,
several SNPs of the QC gene were suggested to determine, in combination with other
factors, the radial BMD. Overall it is suggested that QC may contribute to the
susceptibility of osteoporosis. (Ezura 2004)

Glutaminyl cyclase
Discovery and Early Research
Glutaminyl cyclase (QC) (E.C. 2.3.2.5) is responsible for post-translational
cyclization of amino terminal glutaminyl residues forming pyroglutamic acid. The first
evidence of an enzyme responsible for such a conversion occurred in 1938 when
Damodaran et al. observed ammonia formation due to proteolysis of wheat gluten in the
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presence of crude papain. (Damodaran 1938) This discovery was followed in 1963 with
the publication of enzymatic cyclization of glutamine and glutaminyl peptides. (Messer
1963) In 1965 glutaminyl cyclase was first identified and purified from dried papaya
latex demonstrating QC activity in plants. (Messer 1965) This was followed by
observation of QC activity in different mammalian tissues (Busby Jr. 1987; Bockers
1995) and bacteria (Chen 1989; Beck 1994). Though the amino acid sequence of plant
and bacterial QCs varies substantially from mammalian QCs, the amino acid sequence of
QCs is highly conserved from yeasts to humans. Figure 3 demonstrates an amino acid
alignment for QC from various species demonstrating the conservation of the sequences.
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NLVGRTQASINPSEIISEPRFLEY
~MGMKYVLPLRLIGLAYH"^FQVHRVTG
WELSYEQfHAAKXkj
EAI
AEGTSIS^5*QNDBaPLi.ISiYPG|PGSSAARQHfeOP^-PiQAt#irLilDTpLSQT|Y
TSQTirVS!»IKQNi»HPILIEiVPGi?GSyAVSQKlKHPjQ-GSQAG|L\iiEDT|QSHTiY
CW>FTNTTRFKEl|APIMVP)|l\7DfeQHRQVGDY|QsHp-NiG—»TJg»DAJgTDTTlL
SH-LSDKLHLREAiDKIWPltVVGlTiraSIVREylvQsfe-E^D—tD\^VKSpHDH-All
NPDSGMHKSTKKl|LPFI}RT^VPG|EGSREIQRFllEH|inrr^GElAVtoQAlisEl3GiR

Figure 3: Protein sequence alignment QC from various sources. The
sequence of QC from yeasts to humans is highly conserved and differs significantly from
plant and bacterial QCs. The light shaded areas represent areas of sequence identity
among all species. The darker shaded areas represent areas of high sequence homology
representing substitutions in only one sequence. The alignment was produced using
Clustal W.
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Plant Glutaminyl Cyclase
Plant QCs appear to serve a different function than animal QCs due to the lack of
nervous system and/or peptide hormones in plants. While attempting to determine the
physiological function of plant QCs, Armani et al. first demonstrated the rate of
spontaneous N-terminal glutamine cyclization was too slow to account for the observed
in vivo cyclization. Furthermore, the presence of the pGlu peptides in seed storage
proteins suggested a role for QC in plant protein storage and secretion. Other proposed
functions include specificity of binding and protection from proteolysis. (Amrani 1997)
Research involving plant glutaminyl cyclase began with the purification of papaya
QC. Papaya QC, a basic protein with pi near 9.0, was purified by cation exchange
chromatography. Gel filtration chromatography was used to determine the size of papaya
QC at approximately 25 kDa.

Papaya QC is stable in the pH range from 4 to 11 with its

optimum activity around 8.4 - 9.4, depending on substrate. (Messer 1965) Substrate
specificity studies and kinetic analyses of purified papaya QC (Gololobov 1994;
Gololobov 1996) revealed similar parameters to the purified mammalian QCs. (Busby Jr.
1987; Fischer 1987) The enzymatic mechanism of papaya QC was proposed to involve a
simple intramolecular cyclization of the glutamine residue to a pyroglutamic acid residue
from studies on pH and temperature dependency, proton inventory, and molecular
modeling rather than the alternative double-displacement mechanism. (Gololobov 1994)
Further studies of plant QCs resulted in the purification of papaya QC to near
homogeneity allowing further characterization and stability studies. Research revealed
the protein lacked disulfide bridges and covalently linked phosphate groups. The
extreme stability of the protein was further demonstrated by the resistance to proteolysis
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by papaya cysteine proteinases, trypsin, and chymotrypsin. Spectral studies
demonstrated papaya QC was composed of greater than 50% p-sheets and less than 5%
a-helices, quite different from the predicted structure of mammalian QCs at the time.
(Oberg 1998; Zerhouni 1998) These results were verified by the elucidation of the
papaya QC crystal structure. (Azarkan 2005; Wintjens 2006) Further plant QCs were
identified mArabidopsis thaliana, Glycine max, Solarium lycopersicum, Lotus japonicus,
and Zea mays based on similarities in DNA sequence.
In 2006 the crystal structure of C. papaya, shown in figure 4, was resolved
providing the first crystal structure for the plant, bacteria, and parasite QC archetype.
The structure was shown to contain a five-bladed beta-propeller coordinating one zinc
ion, with two additional alpha-helices and one beta hairpin. The zinc was determined to
maintain a role in the structural integrity of the enzyme along with other structural
features observed such as large hydrophobic pockets. The enzyme active site was
deduced by structure with Tris inhibitor bound and sequence alignment. Highly
conserved residues such as W83, Wl 10, W169, Q24, E69, N155, K225, F22 and F67
have a suggestive role in catalysis. (Wintjens 2006) The crystal structure of the plant
QC demonstrated major differences when compared to the predicted structure of human
QC provided by Booth et al. (Booth 2004)
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Figure 4: Crystal Structure of C. papaya QC. Crystal structure of C. papaya
QC dimer bound to inhibitor Tris and acetate ion. The active site region is located near
the inhibitor binding site.

Bacterial Glutaminvl Cyclase
The cyclization of glutamine to pyroglutamic acid with ammonia release was
observed in 1989 in Streptococcus bovis. (Chen 1989) Though the enzyme has not been
isolated from this species, protein sequence homology searches reveal sequences in many
different bacteria, including Streptococcus and Caulobacter, with high amino acid
sequence homology to plant QC. However, as seen with plants, the bacterial QCs do not
have a high sequence identity with mammalian QCs. This suggests the bacterial QCs and
plant QCs may have evolved from a common ancestor. The protein sequence alignment
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of selected plant and bacterial QCs is shown below with the human QC protein sequence.
The alignment demonstrates a 61% identity among C. papaya and A. thaliana protein
sequences. The C. crescentus and S. pyogenes QC sequences contain a 43% and 30%
sequence identity with the C. papaya sequence. The plant and bacterial sequences all
have less than 10% sequence identity with the human QC. Figure 5 represents the amino
acid sequence alignment for the plant and bacterial QCs.
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papaya
thaliana
crescentus
pyogenes
sapiens

MSRRNFWLLILAYG
LVL
MATRSPYKRQTKRSMIQSLPASSSASSRRRFISRiaiFAMMIPLALLSGAVFLFFMPF
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LAA
MSIMITKG
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SSA
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crescentus
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TTCSRPSS
RVYIVEVLNEFPH
/YAENDTLFEi
NSWGQSSGSSLDLSHRINEIEWAEFPH
LYAGNDTLFEB
PVLAAPAP
VGGYKWKSYPH
[•YRDG-FIFEl
EQLNNNHILLI
QVRLLRTYSY
LRQIAEGTSISEMWQNDLQPLLIERYPGSPGSYAARQHIMQRIQRLQADWVLEIDTFLi

papaya
thaliana
crescentus
pyogenes
sapiens

-ISVRQVALQTGKVENIHKMDDSY|GHLTLLNEKLYQWWLKNIGFIY|RRTLS
-|SVRKVDLRTGKVEII.EKMDNTY|GHLTLLGERLFQVAWLTNTGFTY|LRNLS
.-IFIP^WNLETGAIEAERTIDSRY|GHIVDWKNR¥YALTWTDQVGFIY|IDSFE
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sapiens
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papaya
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crescentus
pyogenes
sapiens

GHRVIRMBliYIMGEVWail^rDCifeRISAKDBTLLGWILLPHiRKKLIDE
GREVRYHraklNNEVWHvfcDCfeRISPKD|SLLGWILLSK|sRGLLKS
GVPVTK|^^P»VKGELlfflv|fcTRiARIDVATiRVKGWIELAGiLPEAGVR
SVPI SMMHfcvDGYLYHlWTNTJvKLQPDSiKVVATYDI SP HLKALNLD
RGTSQLHGMDLLVLLDLIGAPNPTFPNFFPNS— ARWFERLQAIEHELHELGK.KDHSLE

papaya
thaliana
crescentus
pyogenes
sapiens

G--FRDIPSMMWDQENK|IF
G—HRGIDS^MWDSDRQILF
G--DRD-DWHKDAAGD|LF
KSHYPDLN^HHH"LDQQ|FL
G-RYFQNYSYGGVIQDDHIPFL:

tiFEIKLHLVRHRIPDGYIERHCLNLRDNT
KLYQIKLKQASAKSGN-YIEQQCLV
E-FEIKLTEAN
CEWLD
/PVLHLIPSPFPEVWHTMDDNEENLDESTIDNLN

Figure 5: Protein sequence alignment of plant and bacterial QC. Dark
shaded areas represent areas of sequence identity among all plant and bacterial species.
Light shaded areas represent areas of conserved substitutions within the plant and
bacterial proteins. Sequences include C. papaya (AAC27745), A. thaliana
(NP_567727.1), C. crescentus (AAK24617), S. pyogenes (AAK33505). H. sapiens QC
protein sequence is included for comparison. The alignment was produced using the
Clustal W program.
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Mammalian Glutaminyl Cyclase
A mammalian QC capable of converting N-terminal glutamine residues to
pyroglutamic acid residues was independently discovered in 1987 in bovine pituitary and
rat hypothalamus by Fischer et al. (Fischer 1987) and pig pituitary, rat brain, and human
B-lymphocytes by Busby et al. (Busby 1987). Fisher et al. demonstrated the QC activity
by monitoring conversion of Gln-GnRH to pGlu-GnRH by reverse-phase HPLC. The
QC from bovine pituitary had a molecular weight of 43,000 - 55,000 Daltons verified by
gel filtration and a pH optimum of 8.0. Kinetic studies revealed the QC followed
Michaelis-Menten kinetics with a Km value of 63 uM and Vmax of 690 pmol/ug/hour.
These results were confirmed by substrate specificity studies. These studies also
demonstrate the QC was not able to act on internal glutamine residues suggesting QC
activity occurred in the later stages of processing. Subcellular distribution studies
revealed the QC was fractioned along with secretory granules. Vesicle lysis without
detergent resulted in release of QC indicating QC was not an integral membrane protein.
Inhibition studies revealed addition of ATP, glucose-6-phosphate dehydrogenase,
glucose, NADP+, or EDTA had minimal effect on enzyme catalysis. (Fischer 1987)
Busby et al. further confirmed the N-terminal cyclization reaction occurred very
slowly under physiological conditions using the conversion of Gln-His-Pro-NFb to pGluHis-Pro-NH2 for analysis. Addition of a QC enzyme from pig pituitary, rat brain, and Blymphocytes catalyzed this reaction. Porcine pituitary QC was shown to be a
glycoprotein with molecular weight 55,000 Daltons measured by gel filtration and a pH
optimum of 7.2 - 7.5. Affinity studies also identified important sulfhydryls within the
enzyme. Enzyme activity was rapidly lost below pH 5.0 and above pH 8.0. Further
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purification by DEAE chromatography using step gradients resulted in two activity peaks
with Km and Vmax values of 0.2 mM and 0.038 umol/mg/min for peak 1 and 0.6 mM
and 0.023 umol/mg/min for peak 2, respectively. DEAE purification of QC from human
B-lymphocytes resulted in one peak of activity with specific activity of 0.015 nmol/hr/ug.
Inhibition studies revealed inhibition by 1,10-orthophenanthroline and stimulation by
EDTA for the human QC. In preliminary studies, QC from bovine adrenal medulla was
contained in the soluble chromaffin vesicle fraction further suggesting the inclusion of
QC in secretory pathway processing. (Busby 1987)
Preliminary work relied on radioimmunoassay and HPLC analyses to study QC
activity. In 1988, a radioimmunoassay was presented by Koger et al. (Koger 1989).
Independently Consalvo et al. developed an improved HPLC assay. In this assay both
model peptide substrate containing N-terminal glutamine residues and product containing
N-terminal pyroglutamate residues were monitored by HPLC with fluorometric detection.
(Consalvo 1988) Shortly following a coupled spectrophotometric assay for QC was
published by Bateman in 1989. This assay utilized the liberation of ammonia upon Nterminal glutamine cyclization of a substrate. A second reaction, involving <xketoglutarate, glutamate dehydrogenase, and NADH, using the ammonia, produced
glutamate and NAD+. The NADH oxidation followed at 340 nm allowed the QC activity
to be quantified. (Bateman 1989)
In 1991, Pohl et al. purified QC to homogeneity from bovine anterior pituitary.
Purification included extraction from bovine anterior pituitary secretroy granules
followed by various FPLC techniques and IEF-PAGE under non-denaturing conditions
and SDS-PAGE. The resulting protein was used as a probe to isolate a 2088 bp cDNA
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clone from an anterior pituitary cDNA library. Transfection of COS-7 monkey cells with
the predicted QC cDNA construct resulted in expression of a 361 amino acid protein with
QC activity. Nucleotide sequencing revealed the first 27/28 amino acids contained
features of an endoplasmic recticulum signal sequence. Using Northern blot analyses
various bovine brain regions were probed with QC mRNA demonstrating the highest
expression levels found in anterior pituitary and striatum. QC mRNA was also expressed
in lower levels in neurointermediate pituitary, cerebral cortex, hypothalamus, anterior and
posterior thalamus, cerebellum, hippocampus, and retina. QC mRNA was observed to a
small extent in brain stem, heart atrium, heart ventricle, kidney, thymus, and skeletal
muscle. No expression was observed in spleen, lung, or liver. These expression patterns
are similar to those of PAM. This observation along with the signal sequence prediction
and substrate specificity studies further indicate QC is involved in secretory pathway
post-translational enzyme processing. (Pohl 1991)
In 1994, Song et al. expressed human pituitary QC by isolating a human
pituitary cDNA clone from a human pituitary cDNA library. The human QC sequence
was predicted by screening the human library with primers designed against the bovine
QC sequence. The cDNA coded for a 361 amino acid protein of molecular mass 40,876
Daltons. Expression of two QC constructs, one containing a maltose binding protein
(MBP) domain and another containing a poly-hisitidine tag, in bacteria resulted in
purification of active enzyme by affinity chromatography. Expression was confirmed by
western blot using polyclonal peptide antibodies raised against the bovine QC sequence.
The MBP-hQC was 83,000 Daltons and the poly-His-hQC was 40,000 Daltons had
specific activities of 10 nmol/min/mg and 1500 nmol/min/mg, respectively. Substrate
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specificity studies revealed the poly-His-hQC had no detectable reactivity with substrate
containing an N-terminal glutamate residue or large aromatic groups in the second
position. Kinetic studies of various substrates revealed a kcat/Km of 85.5 min^mM"1 for
Gln-Gln-Gln, 79.5 min" W " 1 for Gln-Gln, 58.6 min^mM"1 for Gin-Ala, 11.7 min^mM"1
for Gln-Gly, and 4.61 minVM - 1 for Gln-NH2. (Song 1994)
Further examination of expression levels of QC in bovine and porcine pituitary
and hypothalamus was completed using immunocytochemistry and in situ hybridization.
QC was found more abundant in pituitary than hypothalamus. These studies revealed a
specific pattern of QC expression in certain cell types suggesting the QC N-terminal
conversion is less widespread than the PAM C-terminal conversion. The high expression
levels of QC did not coincide with the highest levels of known pyroglutamate peptides.
(Bockers 1995)
Sequence analyses of mammalian QCs by Temple et al. revealed the conservation
of two cysteine residues among all sequences. Using a poly-His-hQC heterologous
protein, the two cysteine residues were mutated demonstrating a slight decrease in
enzyme activity. These results suggest the two thiols are not essential for catalytic
activity. (Temple 1998)
Bovine QC tissue distribution was examined by immunoreactivity and enzyme
activity in 1999 by Sykes et al. QC was observed to be abundant in the brain and
pituitary by both methods. Antibody specificity was observed in bovine hippocampus,
hypothalamus, kidney, striatum, and anterior pituitary. The specific activity of bovine
QC ranged from 60 nmol/min/mg to 3 nmol/min/mg in order of decreasing activity from
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thymus, hippocampus, hypothalamus, kidney, striatum, adrenal, spleen, anterior pituitary,
and thyroid. (Sykes 1999)
In 2002, three continuous spectrophotometric assays were developed to monitor
QC acitivity. In these assays, one chromogenic substrate, glutamine-p-nitroanilide (GlnpNA), and two fluorogenic substrates, glutaminyl-2-naphthylamide (Gln-BNA) and
glutaminyl-4-methylcoumarinelamide (Gln-AMC) were used to follow QC activity. All
assays required the addition of a secondary enzyme, pyroglutamate aminopeptidase, to
release the chromogenic or fluorogenic component monitored. (Schilling 2002)
Expression studies in bacteria and yeasts were followed by the expression of
human QC in insect cells. Booth et al. completed the expression of human QC in
Drosophila S2 cell culture under the control of an inducible promoter and fused to a BiP
secretion signal. Purification of human QC was completed with dye affinity
chromatography directly from cell culture. The fully active enzyme was 37,000 Daltons
and confirmed by peptide mass mapping and Western blotting. The enzyme was
confirmed to contain a disulfide bond and contained one glycosylated asparagine residue,
N49, verified by enzymatic deglycosylation and amino acid mutation. (Booth 2003)
Snake venom glutaminyl cyclase was identified in 2006. The presence of QC in
venom glands was predicted due to the presence of various pyroglutamate containing
peptides in snake venom. This study resulted in cDNA isolation and enzyme expression
in bacterial expression system. Expressed protein was verified by sequencing and
aligned with known QCs demonstrating the evidence of QC in peripheral tissues.
(Pawlak2006)
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Enzymatic Reaction and Inhibition Studies
Initial insights into the QC mechanism were provided by Temple et al. Due to the
problem of protein expression in inclusion bodies with previous bacterial expression of
human QC, another hQC construct using the glutathione-S-transferase (GST) fusion
protein was developed. Affinity purification using the sepahrose-4B glutathione column
resulted in purification of hQC-GST with specific activity of 1000 nmol/min/mg. The
expressed protein was sensitive to DEPC and acetyl-imidazole suggesting the
involvement of histidines or tyrosines and a possible acid/base catalysis mechanism.
(Temple 1998)
Further evaluation of the QC mechanism revealed essential histidine residues in
human pituitary QC. Treatment with DEPC inactivated recombinant human QC with the
modification of three essential histidine residues. However, sequence analyses revealed
four conserved histidines among mammalian QCs. Mutational studies of all four
histidine residues to glutamine residues resulted in two inactive enzymes (H140->Q140
and H330->Q) and two enzymes with increased Km values (H307->Q and H319->Q).
These results suggested the H140 and H330 played a role in catalysis and H307 and
H319 played a role in substrate binding. (Bateman 2001)
Further studies revealed evidence for a disulfide bond important to catalytic
activity. Schilling et al. expressed human QC in the secretory pathway of yeasts.
Following purification, recombinant QC was analyzed by MALDI-TOF to verify correct
proteolytic processing resulting in a 38,795 Daltons protein containing N-glycosylation at
both predicted sites and CD spectroscopy to verify correct secondary structure. The
enzyme had similar kinetic values to human QC expressed in bacteria. Enzyme activity
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was almost completely eliminated by addition of DTT suggesting the presence of an
important disulfide bond. Fluoresence spectra suggest the loss of enzyme activity is due
to change in protein conformational change. (Schilling 2002)
In 2003, inhibition studies identified human QC as a metalloenzyme.
Heterocyclic chelators such as 1,10-phenanthroline and dipicolinic acid were shown to
inhibit QC in a time-dependent manner while EDTA effect was negligible. The presence
of Zn+2 resulted in reactivation of inactivated enzyme while Co+2 and Mn+2 had little
effect on enzyme activity. These results demonstrate the importance of the Zn in
enzyme catalysis. Competitive inhibition was demonstrated with imidazole and
imidazole derivatives. (Schilling 2003) Furthermore, these results provide some insight
into the mutation studies by Bateman et al. suggesting the mutated Hisl40 and His330
are necessary for metal binding. (Bateman 2001)
Schilling et al. suggest a mechanism in which the metal ion interacts with the
nitrogen to provide the correct positioning of the nitrogen to the y-carbonyl carbon. An
alternative suggestion is that the metal polarizes the y-amide group of the substrate while
stabilizing the oxanion formed by nucleophilic attack of the a-nitrogen on the y-carbonyl
carbon. The QC reaction proposed by Schilling is shown in figure 6.
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Figure 6: Glutaminyl Cyclase Reaction. The enzymatic reaction of glutaminyl
cyclase including the predicted intermediate. (Schilling 2003)

Substrate specificity studies were completed by Schilling et al. in 2003 for both
plant and mammalian QCs.

Experiments demonstrated nearly all dipeptides and

tripeptides tested were more reactive with the papaya QC. Higher turnover numbers were
observed for substrates containing large hydrophobic residues C-terminal to the Nterminal glutamine. Both plant and mammalian QCs had similar specificity constants for
oligopeptides. Mammalian QC activity was highly dependent on substrate size and pH
compared to papaya QC, whereas a similar dependence on ionic strength was observed
between enzymes from the two species. (Schilling 2003)
Isolation of murine QC presented further information absent of specific catalytic
properties and inhibitors for mammalian QCs. Murine QC (mQC) was identified in an
insulinoma cell line by enzymatic activity. RT-PCR was used to amplify the gene from
the cell line and expression in yeast resulted in purification of the mQC. Murine QC is a
glycoprotein of approximately 36,000 Daltons. Specificity studies demonstrated the
specificity constants of mQC were somewhat lower than hQC. Similar to hQC, the mQC
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demonstrated a low specificity for dipeptides and slightly higher specificity for longer
peptides. Competitive inhibition was observed in the presence of imidazole derivatives,
with slightly stronger inhibition observed for 1-substituted imidazole derivatives. Metal
chelators 1,10-phenathroline and dipicolinic acid also inhibited mQC, but EDTA did not.
Murine QC was also competitively inhibited by cystamine and several cystamine
derivatives containing both an amino and thiol group. Inhibition by thiols has been
observed in several aminopeptidase species. Such inhibition had not been observed for
other mammalian QCs. Isolation of mQC also verified the presence of one zinc ion per
catalytic unit of mammalian QC. (Schilling 2005)

Human QC Crystal Structure
Crystal structure isolation of human QC followed the expression of human QC
isolated from bone marrow in a bacterial system. A bacterial construct containing human
QC and a fused with a poly-histidine tag and FactorXa was developed allowing high level
expression and purification of enzyme near homogeneity. The enzyme was verified by
both enzymatic and structural examination. (Huang 2005)
Human QC crystal structures were presented in free-form, bound to substrate, and
bound to three different imidazole inhibitors providing more definitive evidence of
enzyme mechanism. Human QC structure revealed an a/p scaffold similar to that of zinc
aminopeptidases. (Huang 2005) These results validated those of Booth et al. (Booth
2004) Two different binding modes were also identified due to different orientations of
the Trp207 indole ring. (Huang 2005)

28
The authors identified specific residues important in binding and/or substrate
stabilization and catalytic residues. The enzyme active site contains a single zinc ion
coordinated by one water molecule and three conserved residues, Asp 15 9, His330, and
Glu202. The zinc bound water molecule is replaced during inhibitor binding. The
authors propose a catalytic mechanism in which the conserved Glu201 transfers a proton
from the a-amino group of the substrate to the leaving amide group. The zinc ion then
stabilizes the substrate while a conserved Asp248 stabilizes the leaving amide group.
(Huang 2005) A kinemage developed from the crystal structure is shown in figure 7.
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Figure 7: Crystal Structure of human QC. The image on the left represents the
overall 3-D structure of human QC (PDB ID 2AFO). The image on the right represents
the active site residues of the structure in teal with amino acid type and number and the
zinc ion in purple.
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Relationship to Bacterial Aminopeptidase
Human QC and a bacterial zinc aminopeptidase have been shown to share a
common fold and active site though less than 16% sequence conservation is observed.
(Booth 2004) This relationship could hold some clues about the evolution of the
enzymes. The following study utilized a predicted 3-D structure of human QC expressed
in Drosophila S2 cells. (Booth 2003) Overlay of the human QC 3-D structure with the
bacterial aminopeptidase from Aeromonas proteolytica revealed a similar fold consisting
of a central 8-stranded P-sheet surrounded by six a-helices on one side and three on the
other with the active site located at the C-terminal end of the central two strands of the Psheet. No similar overlay was identified between the plant QCs and bacterial zinc
aminopeptidases. (Booth 2004) The human QC and bacterial aminopeptidase overlay is
shown in figure 8.
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Figure 8: Structure of human QC and zinc bacterial aminopeptidase. (A) The
predicted 3-D structure of human QC. (B) The predicted 3-D structure of zinc bacterial
aminopeptidase. (C) Overlay of human QC and zinc bacterial aminopeptidase.

The amino acids within the hQC active site were also conserved within the
predicted 3-D structure compared to the active site of the bacterial zinc aminopeptidase.
Several of the conserved residues bind two zinc metals in the aminopeptidase, though
only one metal has been identified in hQC. (Booth 2004)
Both human QC and bacterial aminopeptidase are both inhibited by metal
chelators such as 1,10-phenanthroline, dipicolinic acid. This further suggests a
relationship between enzymatic activity which is most likely due to the importance of
Zn+2 for catalysis of both enzymes. (Schilling 2003)
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Multiple Isoforms
Database analyses have revealed multiple isoforms of QC in many different
species including humans, mice, cows, Drosophila, etc. The isoforms appear on different
chromosomes in all species suggesting the presence of an isoform does not represent a
gene duplication event. Amino acid sequence alignments reveal the conservation of all
catalytic residues and most important binding residues identified by human QC crystal
structure and mutagenesis studies. This suggests a conservation of enzyme activity and
catalysis. Shown in figure 9 are example amino acid alignments of the human QC
isoforms and Drosophila QC isoforms.
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Human QC
MRSGGRGRPRLRLGERGLMEPLLPPKRRLLPRVRLLPLLLALAVGSAFYTIWSGWHR
Human QC--LK -MAGGR
HRRWGTLHLLLLVAALPWAS
RGVSP

RTEELPLGRELRVPLIGSLPEARLRRWGQLDPQRLWSTYLRPLLWRTPGSPGNLQ
Human QC
Human QC-•LK SASAWPEEKNYHQPAI—LNSSALRQIAEGTSISEMWQNDLQPLLIERYPGSPGSYA
Human QC
VRKFLEATLRSLTAGWHVELDPFTASTPLGPVDFGNWATLDPRAARHLTLACHYDS
Human QC-•LK ARQHIMQRIQRLQADWVLEIDTFLSQTPYGYRS FSNIISTLNPTAKRHLVLACHYDS
Human QC
KLFPPGS-TPFVGATDSAVPCALLLELAQALD
LELSRAKKQAAPVTLQLLFLDG
Human QC-•LK KYFSHWNNRVFVGATDSAVPCAMMLELARALDKKLLSLKTVSDSKPDLSLQLIFFDG
Human QC
EEALKEWGPKDSLYGSRHLAQLMESIPHSP
GPTRIQAIELFMLLDLLGAPNPTF
Human QC-•LK EEAFLHWSPQDSLYGSRHLAAKMASTPHPPGARGTSQLHGMDLLVLLDLIGAPNPTF
Human QC
YSHFPRTVRWFHRLRSIEKRLHRLNLLQSHPQEVMYFQPGEPFGSVEDDHIPFLRRG
Human QC-•LK PNFFPNSARWFERLQAIEHELHELGLLKDHSLEGRYFQNYSYGGVIQDDHIPFLRRG
Human QC
VPVLHLISTPFPAVWHTPADTEVNLHPPTVHNLCRILAVFLAEYLGL
Human QC-•LK VPVLHLIPSPFPEVWHTMDDNEENLDESTIDNLNKILQVFVLEYLHL

dQC
dQCLK

MRLLLRNYSLMEAVKRLLPRPRKKIYNLGACFELVDIPKISYNPSELSEPRFLEYSNLSD
— MAIGSWFAAAGLLLLLLP
PSHQQATAGNIG
SQWRD
D

dQC
dQCLK

KLHLREAIDKILIPRWGTTNHSIVREYIVQSLRDLDWDVEVNSFHDHAPIKGKLHFHNI
EVHFNRTLDSILVPRWGSRGHQQVREYLVQSLNGLGFQTEVDEFKQRVPVFGELTFANV

dQC
dQCLK

IATLNPNAERYLVLSCHYDSKYMPG-VEFLGATDSAVPCAMLLNLAQVLQEQLKPLKK—
VGTINPQAQNFLALACHYDSKYFPNDPGFVGATDSAVPCAILLNTAKTLGAYLQKEFRNR

dQC
dQCLK

SKLSLMLLFFDGEEAFEEWGPKDSIYGARHLAKKWHHEG
KLDRIDMLVLL
SDVGLMLIFFDGEEAFKEWTDADSVYGSKHLAAKLASKRSGSQAQLAPRNIDRIEVLVLL

dQC
dQCLK

DLLGAPDPAFYSFFENTESWYMRIQSVETRLAKLQLLERYASSGVAQRDPTRYFQSQAMR
DLIGARNPKFSSFYENTDGLHSSLVQIEKSLRTAGQLE
GNNNMFLSRVS-

dQC
dQCLK

SSFIEDDHIPFLRRNVPILHLIPVPFPSVWHTPDDNASVIDYATTDNLALIIRLFALEYL
GGLVDDDHRPFLDENVPVLHLVATPFPDVWHTPRDNAANLHWPSIRNFNRVFRNFVYQYL

dQC
dQCLK

LAGTEAK
KRHTSPVNLRFYRT

Figure 9: Alignments of QC-Isoforms. Top alignment demonstrates the amino
acid sequence alignment of human QC with isoforms. The bottom amino acid sequence
alignment demonstrates the two Drosophila QC isoforms. Conserved amino acids are
highlighted in grey.
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PC Knock-out Data and QC Microarray Data
Human microarray data
Localization and relative expression levels of several gene products have been
analyzed through the use of microarray and in situ hybridization studies. Microarray
studies characterizing the human QC gene have been primarily involved in studying QC
levels in various disease states compared to normal tissue. Therefore, relative expression
levels for different cell types in humans are not available.

Drosophila microarray data
Microarray studies have demonstrated the relative expression levels of one
isoform of Drosophila QC's (CG32412) mRNA in adult Drosophila melanogaster.
Table 2 demonstrates the tissue studies, relative mRNA levels detected, and enrichment
for the microarray study of gene CG32412. (Chintapalli 2007). Values greater than 100
were considered abundant and values greater than 1000 were considered remarkable.
This study demonstrated the most significant expression levels of mRNA in the crop,
ovaries, hindgut, head, male accessory glands, adult carcass, larval fat body, and testis in
descending order. The enrichment value demonstrates the intensity of the signal in the
tissue examined compared to the whole fly. No experiments were completed for the
other Drosophila QC isoform (CG5679).
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Table 2: Microarray data for gene CG32412.
Tissue Studied
Crop
Ovary
Hindgut
Head
Male accessory glands
Adult carcass
Larval fat body
Testis
Thoracicoabdominal ganglion
Brain
Midgut
Larval tubule
Tubule
Whole fly

mRNA Signal
927 ± 10
896 ± 24
289 ± 4
282 ±13
271 ± 18
196 ±13
140 ±19
139 ± 5
61 ± 2
57 ± 2
50 ± 3
18±3
14 ± 2
405 ± 28

Enrichment
2.30
2.20
0.70
0.70
0.70
0.50
0.30
0.30
0.20
0.10
0.10
0.00
0.00

In situ hybridization studies of various genes throughout the genome provided by
the Berkeley Drosophila Genome Project (BDGP) demonstrated the highest level of
mRNA production in early embryonic stages. In situ images also revealed a high level of
maternal QC-like mRNA in early stages which could lead to the large values obtained in
early development. Later stages of development revealed QC-like mRNA present in the
embryonic hypopharynx. Figure 10 demonstrates the relative amounts of QC-like
mRNA observed throughout the Drosophila life cycle.
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Expression profile of CG32412
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Figure 10: Expression profile of CG32412. In situ hybridization expression
profile obtained from the BDGP database demonstrating the high level of QC-like mRNA
in early Drosophila melanogaster development.

Drosophila melanogaster RNAi mutants of the CG32412 gene products were
developed by the Vienna Drosophila RNAi Stock Center. Inability to produce this
particular Drosophila QC isoforms resulted in a lethal mutation. Embryos were not
viable. No RNAi lines have been developed for the other Drosophila QC isoform.
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Drosophila melanogaster Model System
The Drosophila melanogaster model system is a popular system for biochemical
and biological research due to its small size, ease of culture, and short generation time. It
is one of the few systems whose entire genome is known and various mutant lines are
available from the Bloomington Stock Center. Other important information can be
obtained from FlyBase, a database of University of Indiana, which provides a collection
of genetics and molecular biology information and tools.
The life cycle of D. melanogaster involves complete metamorphism with the life
cycle including an egg, larval form, pupa, and flying adult. The larval stage has three
instars. The complete metamorphosis is temperature dependent with an average life
cycle of 12-15 days.
Flies have four pairs of chromosomes termed 2L;2R, 3L;3R, 4, and either XX or
XY. The L refers to the left arm and the R refers to the right arm. Though recombination
is almost completely absent it is more common in females. This recombination is
controlled in the laboratory by the use of a balancer chromosome, a chromosome whose
normal sequence is scrambled as the result of artificially induced breaks and rejoining,
they are incapable of pairing with their normal homolog during prophase. These
balancers are used in combination with typical phenotypic markers which affect eye
color, eye shape, wing shape, wing vein morphology, bristle color, bristle shape, and
cuticle pigmentation.
Drosophila melanogaster cell lines have been used to express heterologous gene
products. Most commonly used cell lines are the Schneider S2 and S3 cell lines. These
cell lines were derived from primary cultures of late stage D. melanogaster embryos.
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Cells are maintained in an immortalized non-tumorgenic growth. Cells are capable of
growth in Schneider's media with or without heat-inactivated fetal bovine serum (FBS).
(Schneider 1972) The S2 cell line has been proven useful for transient or stable
transfection. Once produced, the cell line is capable of maintaining ability to produce
large amounts of heterologous protein. The use of D. melanogaster cell culture
demonstrates another important use of the D. melanogaster model system.

Peptide Processing Enzymes Homologs
Various secretory pathway modifications such as N-terminal pGlu and C-terminal
amide have been observed in many different Drosophila peptides. The study of
Drosophila peptide processing enzymes has resulted in the expression and purification of
various pathway enzymes from Drosophila melanogaster demonstrating in vitro the
specific predicted enzymatic activity.

Prohormone convertase 2 homolog
The Drosophila homolog of the mammalian PC2 enzyme was first identified in
1999, termed amontillado (amon). Initially one major difference was observed between
the mammalian enzyme and the Drosophila enzyme. Drosophila PC2 expression is
highly regulated during development. Typically expression occurs within the final stages
of embryogenesis mainly within sensory structures according to in situ hybridization
studies. Mutant larvae did not show any gross anatomical differences however a
reduction in specific egg hatching behavior was observed. Expression of PC2 restored
this behavior unless active site residues were mutated. These initial results suggested the
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major role of PC2 in Drosophila involved proper neuronal signaling during the egg
hatching stage. (Siekhaus 1999)
Following the identification of a Drosophila PC2, the cDNA encoding
Drosophila 7B2, was identified in Drosophila. The dPC2 and d7B2 were subcloned into
HEK-293 cells without successful expression of proteolytic active enzyme. This was
followed by the coexpression in Drosophila S2 cells. The expressed dPC2 was active
suggesting the proper maturation of dPC2 requires Drosophila specific enzymatic
processing. (Hwang 2000)
Mutation studies further identified the function of dPC2. dPC2 mutants displayed
partial embryonic lethality, commonly die during the first to second instar, and are
defective in larval growth. These results indicated the dPC2 is required for
embryogensis and larval development and more specifically responsible for regulation of
hatching, larval growth, and larval ecdysis. (Rayburn 2003)

Carboxypeptidase homolog
Scanning of the Drosophila melanogaster cDNA library using probes generated
against the vertebrate carboxypeptidase E identified homologs to human CPE, CPN, and
CPM. Northern blot analyses revealed a potential CPE gene in embryos. Results
suggested a single protein is responsible for carboxypeptidase activity in Drosophila.
(Bernasconi 1994)
Subsequently the silver (svr) gene was identified as the gene responsible for the
translation of previously identified carboxypeptidase proteins. Silver gene mutations are
lethal. Weak alleles resulted in several phenotypic abnormalities. (Setirle 1995)
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Peptidyl glycine a-amidating monooxygenase homolog
Both the monooxygenase (PHM) and lyase (PAL) proteins associated with
mammalian bifunctional PAM protein were observed in Drosophila head extracts.
However, the bifunctional PAM protein was not detected. An active PHM-like protein
was identified by both Northern and Western blot analyses and expressed independently
suggesting the presence of different PHM and PAL genes. Disruption of the PHM gene
resulted in lethality. (Kolhekar 1997)
Further study of the Drosophila amidation enzymes resulted in the validation of
previous research identifying the presence of one monofunctional PHM gene, but also
presented the discovery of two monofunctional PAL genes, PALI and PAL2. dPALl has
a predicted transmembrane domain and is secreted poorly. dPAL2 is predicted to be
secreted and soluble. Upon expression, dPAL2 was secreted and co-localized with
hormone. Coexpression was observed in various neuroendocrine neurons but the dPALl
was more broadly expressed. (Han 2004)

Glutaminyl cyclase homolog
An enzyme capable of QC activity with greater than 60% sequence homology was
expressed, purified, and characterized from D. melanogaster independently by Parker et.
al. (subject of this dissertation) and Schilling et. al. Both groups demonstrated a similar
mode of activity and inhibition in the dQC when compared to human QC. Both groups
also identified the presence of a dQC isoform within the Drosophila genome capable of
QC activity. (Parker 2008; Schilling 2007)
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Peptidomics of Adipokinetic Hormone Processing
Peptidomics techonology has aimed to identify the expressed peptides within in a
cell including all post-translational modifcations. Adipokinetic hormone (AKH), the first
peptide hormone to be sequenced from insects, has been studied extensively. AKHs
regulate the release of lipid (diacylglycerol) and carbohydrate (trehalose) energy
substrates during flight. Cell ablation studies of AKH producing cells resulted in loss of
trehalose release and altered insect function. (Guillaume 2005) These peptide hormones
are synthesized and stored for secretion by neurosecretory cells of the corpus cardiacum.
Once released the AKH stimulates fat body target cells through adenylate cyclase
activation and subsequent cAMP production. cAMP activates the breakdown of
glycogen through conversion of glycogen phosphorylase to its active form. AKHs are
also known to enhance production of inositol triphosphates through phospholipase c
activation which mediate Ca release from intracellular stores. Depletion of internal
calcium storage results in an influx of extracellular calcium which activates
triacylglyceral lipase to release diacylglycerols. Initially, the trehalose in the insect blood
is responsible for providing energy during flight with additional trehalose provided from
glycogen storage. Similtaneously, AKH is stimulating the release of diacylglycerols into
the blood. (Van der Horst 2001)
The AKH gene (FlyBase ID FBgn0004552; CGI 171) is located on chromosome
3L and sequence location 64A7. One gene produces one transcript and one polypeptide.
AKH peptides are synthesized at the rER, transported to the golgi complex, and packaged
into secretory granules for transport. The maturation of AKH requires the activity of
various post-translational processing enzymes within the secretory granules as observed
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by in situ hybridization studies. AKH is produced as a large 79 amino acid precursor
cleaved to produce a 9 amino acid precursor which is subsequently modified to contain
an N-terminal pGlu residue and C-terminal amide. Figure 11 summarizes the maturation
of AKH.

AKH Processing
MNPKSEVUAAVLFMLLACVQCOLTFSPDWGKRSVGGAGPGTFFETQQG
NCKTSNEMLLEIFRFVQSQAQLFLDCKHRE
•^r

Prohormone convertase

QLTFSPDWG

I QC
pQLTFSPDWG

1

PAM

pQLTESPDWNH 2
Figure 11: Maturation of Drosophila AKH peptide hormone.

Drosophila AKH and mammalian GnRH Relationship
The Drosophila AKH and mammalian gonadotropin-relesing hormone, GnRH,
appear to require the same processing for proper enzymatic maturation. A structural and
evolutionary link has been established between the Drosophila AKH receptor and rat
GnRH receptor. This provides some evidence for the relationship between the two
systems because the hormone receptors were shown to contain high sequence identity
among the transmembrane region of the receptors which is normally only observed in
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highly related species. Also, the two receptors were shown to contain common intron
sequences suggesting an evolutionary relationship. (Staubli 2002)
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Specific Aims and Hypotheses
Due to the similarity of Drosophila and mammalian peptide hormone processing
and the presence of other peptide processing enzymes homologs in the Drosophila
genome, we sought to identify a glutaminyl cyclase enzyme in Drosophila. Identification
of this enzyme would complete the peptide hormone processing scheme in insects and
provide the first evidence of such enzyme activity in Drosophila. A complete
characterization of the Drosophila QC could also possibly lead to the use of insect QC as
a possible target for insect pest control.
During initial database searches, multiple putative QC sequences were identified
in Drosophila. Two Drosophila QCs were identified due to a high amino acid sequence
identity to human QC. Both Drosophila QCs were expressed, purified, and characterized
for comparison to the published data for human QC. Following expression and
characterization studies of both Drosophila QC isoforms in our laboratory, another
research group, Schilling and co-workers, published the expression and catalytic
properties of both the Drosophila QC isoforms. All published kinetic properties and
inhibitor studies were in agreement with our research. Therefore, we attempted to study
the location of dQC and dQC-LK transcription and translation products to determine the
biological function of two QC isoforms. This would allow determination of expression
levels of both Drosophila QC isoforms separately and provide a possible explanation of
the specific biological role of the two QC isoforms independently.
The evolution of QC was also examined. It is clear that QC possesses a zinc
aminopeptidase structural fold, suggesting a possible common evolutionary origin.
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Therefore, we attempt to identify promiscuous enzyme activity among the
aminopeptidase and QC enzyme families. Other than the structural link between human
QC and bacterial aminopeptidase, the mammalian post-translational processing system
has been linked to the insect post-translational processing system. Sequence analyses
have identified similarities with between mammalian hormone receptors and Drosophila
hormone receptors suggesting this link in the peptide hormone processing systems.
Therefore, my research aims to compare the enzymatic activity of the bacterial
aminopeptidase and the insect and mammalian QCs. QC and aminopeptidase enzymatic
analyses, along with the use of various phylogenetic tools, will allow a better
understanding of the QC evolution and its relationship to bacterial aminopeptidases.

CHAPTER II
EXPERIMENTAL PROCEDURES
Routine Equipment
Analytical Balance
Autoclaves
Cooler
Freezer
Horizontal Gel Apparatus
Incubator
Incubator/Shaker
Laminar flow hood
Microcentrifuge
Microwave
pH Meter
pipettes
Power Supply
Refrigerator
Spectrophotometer
Microtiter plate reader
Fluorometer
Thermocycler
Vertical gel apparatus
Western transfer apparatus
MALDI-TOF

Citizen CY204 and CT604
Amsco 3031-S and Amsco Steris Lab 250
Master-Bilt Products
Kenmore
Kodak BioMaxQS710
Fisher Isotemp Incubator Model 630D
New Brunswick Scientific Innova 4000
NuAire
Eppendorf 5415 C
General Electric
Corning 240
Rainin Corporation P-1000, P-200, P-100, and P20
Fisher FB105
Kenmore
Hitachi U2000
BioTek EL800
Hitachi F2000
Ericomp Power Block System
NovexXCell
Bio-Rad Trans-Blot
Bruker Microflex series

Solutions
Luria-Bertani (LB) media
10g/L
Tryptone peptone
5 g/L
Yeast Extract
lOg/L
NaCl
15 g/L
Agar
SOC media
20 g/L
5 g/L
10 mM
2.5 mM
10 mM
10 mM
20 mM

Tryptone peptone
Yeast Extract
NaCl
KC1
MgCl2
MgS0 4
Glucose

Phosphate Buffered Saline (PBS), pH 7.4
140 mM
NaCl
2.7 mM
KC1
10 mM
Na 2 HP0 4
1.8 mM
KH 2 P0 4
TBE buffer
89 mM
2 mM
89 mM

Tris base
EDTA
Boric acid

TE buffer
10 mM
1 mM

Tris
EDTA

Western Blot Transfer Buffer
0.75 g/L
Glycine
19.38 g/L
Tris Base
20 mg/L
SDS
200 mL
Methanol
Western Blot Solution
10 mM
Tris base
0.9 %
NaCl
0.1 %
Tween
Hybridization Solution
50 %
Formamide (deionized)
5X
SSC
100 ug/mL
DNA (boiled salmon sp
50 ug/mL
heparin
0.1 %
Tween-20
20XSSC(100mL), pH7.0
17.5 g
NaCl
8.8 g
sodium citrate
PTX (500 mL)
50 mL
500 uL

1 OX PBS
Triton X-100

PBT (500 mL)
500 mL
5g
500 uL

IX PBS
Bovine serum albumin
Triton X-100
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General Methods
Glutaminyl cyclase spectrophotometric enzyme assay
Glutaminyl cyclase activity was tested using a previously published
spectrophotometric assay. (Bateman 1989) This assay employs the ability of glutamate
dehydrogenase to detect the ammonia released from the QC reaction. Typical QC
reaction substrates used are Gln-NHb and Gln-tBE. The reaction of glutamate
dehydrogenase with ammonia is coupled to the oxidation of NADH to NAD+ resulting in
a loss of absorbance at 340 nm. Routine experiments required a cocktail composed of 20
mM a-ketoglutarate, 1.7 mM NADH, 8.5 mM Gln-NH2, and 24 U glutamate
dehydrogenase in a total volume of 6.5 mL 50 mM MOPS at pH 7.5. Enzyme assays
were completed in duplicate. First 50 uL of the properly diluted QC source were added
to all test tubes. Additions of 100 uL of the cocktail mixture were added to one set of test
tubes. These reactions were allowed to incubate at 37°C for 65 minutes in a water bath.
After 60 minutes, 100 uL cocktail was added to the other set of test tubes, which were
then allowed to incubate at 37°C for 5 minutes in a water bath. The reactions were
stopped simultaneously by addition of 500 uL cold water. The absorbance of each tube
was measured at 340 nm using a Hitachi U-2000 spectrophotometer. Differences
between the two time points represented the change in absorbance over 60 minutes.
Typically, 0.01 absorbance units represented the production of 1 nanomole of product.
The assay was used with varying substrate and/or inhibitor concentrations for kinetic
analysis. Detailed protocols follow.
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Glutaminyl cyclase fluorometric enzyme assay
Alternatively, QC activity was analyzed using a fluorometric enzyme assay
previously described by Schilling et. al. (Schilling 2002). This assay employs the release
of a fluorometric compound upon cyclization of an N-terminal Gin by QC activity
followed by removal of the pGlu residue by a pyroglutamate aminopeptidase (PGAP).
Two substrates were used for these assays, Gln-AMC and Gln-PNA at a concentration of
0.05 mM. Pyroglutamate aminopeptidase was obtained from a collaborator and 2.5 uL
was used in each assay. Initially, the substrate and PGAP were combined in a 20 mM
Tris buffer at pH 7.5 to a total volume of 625 uL. Addition of 25 uL properly diluted QC
source was used to initiate the reaction. Excitation/emission wavelengths for Gln-AMC
were 380/465 nm and 320/410 in the case of Gln-PNA, respectively. Assays were
allowed to proceed for 5 minutes. All fluorometric analyses were completed using a
Hitachi F-2000 spectrophotometer.

Aminopeptidase spectrophotometric assay
Aminopeptidase (AP) activity was tested using a colorometric assay. 0.1 mM
leucine para-nitroanilide (leu-pNA) was used as a substrate. In the presence of active AP,
the N-terminal leucine is cleaved resulting in the release of pNA, a yellow colored
compound. Routine assays required the addition of substrate and 100 uM Zn to 50 mM
MOPS pH 7.5 to a final volume of 500 uL. Addition of 5 uL AP source was added to
initiate reaction. Typical assays were allowed to proceed overnight. Release of pNA was
measured spectrophotometrically at 412 nM using a Hitachi U-2000.

Polymerase chain reaction f PCR)
Polymerase chain reactions (PCR) were completed using a standard protocol. In
reactions forward and reverse primers were designed with a minimum of 18
complementary nucleotides, a G-C content of 40% - 60%, and within 0.5°C difference in
melting temperature. Typical reactions contained 200 ng of each primer, 0.3 uM each
dNTP, IX reaction buffer containing varying concentrations of MgCk, and either 1 U
Taq polymerase or 2 U PfX polymerase (Invitrogen). Reactions were completed with
one melting cycle at 95°C for 5 minutes followed by 25 to 30 cycles at 95°C for 1
minute, melting temperature for 1 minute, and 72°C for 2 minutes. A final extension
cycle of 72°C for 10 minutes was used.

Polyacrylamide gel electrophoresis and Western blotting
Sodium dodecyl-sulfate polyacrylamide gel electrophoresis (SDS-PAGE) was
used routinely throughout experiments. Typically 10% or 15% pre-cast Tricine gels
(Invitrogen) were used for protein separation in Tricine buffer (Invitrogen). Following
SDS-PAGE proteins were transferred to a nitrocellulose membrane (Invitrogen) at 250
mAmps for 1 hour at 4°C using Western blot transfer solution. Membrane blotting
included a 1 hour wash in 5% non-fat milk, 1 hour wash in varying dilutions of primary
antibody, three 10 minute washes in western blot solution, 1 hour wash in 1/10,000
dilution of secondary antibody, three 10 minute washes in western blot solution, and
developing with minimal volume NBT/BCIP (Sigma) until precipitate formed.
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Mass spectroscopy
Routine MALDI-TOF utilized the Bruker Daltonics Microflex. Typical samples
were prepared by in-gel trypsin digestion. Protein samples were separated by SDSPAGE and visualized with Simply Blue SafeStain (Invitrogen). Protein bands for
analysis were removed with a razor blade and placed in clean microcentrifuge tubes.
Two 45 minute washes of 100 mM NH4HCO3 in 50% acetonitrile at 37°C removed all
stain from the gel slices. Next gel slices were dehydrated for 5 minutes at room
temperature in 100 uL 100% acetonitrile. A 10 to 15 minute lyophilization followed to
remove all acetonitrile. Next gel slices were allowed to incubate in 20 uL trypsin gold
(20 ug) at room temperature for 1 hour. Gel slices were covered with 40 mM NH4HCO3
and allowed to incubate overnight at 37°C. The following morning, protein fragments
were extracted from the gel slice with one 10 minute wash with 150 uL water and two 60
minute washes in 50% acetonitrile, 5% TFA at room temperature. The extractions were
then pooled and dried in a speed vacuum at room temperature for 4 hours. To clean the
samples, the pellet was resuspended in 10 uL 0.1% TFA. Protein sample was loaded onto
CI8 ziptips previously equilibrated with 10 uL 50% acetonitrile followed by 0.1% TFA.
Matrix was washed with 0.1% TFA and eluted with 50% acetonitrile, 0.1% TFA. For
non-digested protein analysis only the CI8 protocol was required to remove salt from
sample. Protein samples were mixed 1:1 with a 10 mg/mL matrix solution, a-cyano-4hydroxycinnamic acid (Sigma) and sinapinic acid (Sigma) were commonly used matrices
which were prepared fresh by dissolving in 50% acetonitrile, 0.1% TFA.
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Peptide Hormone Expression in Drosophila Schneider 2 (S2) Cells
General maintenance of Drosophila S2 cells
Drosophila S2 cells (Invitrogen R690-07) were maintained in adherent culture in
Schneider's Drosophila medium (SDM) (Invitrogen) supplemented with 10% heatinactivated fetal bovine serum (Hyclone). Cells were initiated from liquid nitrogen stock
by quickly thawing at 37°C and transferring contents to complete SDM after an initial
washing step. Cells are initially transferred to a T-25 cm2 flask. Cells were allowed to
incubate at 28°C with loosened caps for aeration. After a concentration of greater than 2
X10 6 viable cells per mL, the culture was sub-cultured at a seeding density of 5 X 10
viable cells per mL for subsequence growth in a T-75 cm2 flask. Cell viability was
determined using trypan blue exclusion methods and a hemacytometer chamber with
manual counting. To maintain the cell line, frozen stocks were generated at a
concentration of greater than 1 X 107 viable cells per mL in SDM with 10% DMSO.
S2 cells were adapted to grow under serum-free conditions in suspension culture
in an attempt to eliminate contaminating proteins in media. Cells were subjected to
increasing amounts of Serum Free Medium (SFM) (Invitrogen 10797) until cells were
capable of maintaining normal growth rates under serum free conditions. Cells were
maintained in 100% SFM in suspension culture at 28°C at 125 rpm in shaker flasks.
Typical cell cultures were maintained at greater than 1 X 107 viable cells per mL with a
seeding density of 1 X 105 viable cells per mL for subculturing. Similar initiating and
freezing techniques were used in serum free cell culture.
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Cloning and expression of Drosophila Adipokinetic Hormone (AKH)
Drosophila adipokinetic hormone (AKH) was obtained by PCR amplification
from the Drosophila S2 cell genome using the following primer set: 5'GCTGAATCGAAGTGGACCAG-3' and 5'-GTGTGCGTGCTAGACATCGT-3\ PCR
reaction required an annealing Tm of 60°C and used 2 U Pfx proofreading polymerase.
Immediately following PCR amplification, 1 U Taq polymerase was added to facilitate
the addition of adenine overhangs for subsequent TOPO reactions. PCR product was gel
purified and subsequently ligated into the pMT/V5-His-TOPO vector (Invitrogen) by
combining the purified PCR product, vector, and concentrated salt solution followed by
incubation at room temperature for 5 minutes. Constructs were transformed into One
Shot TOP 10 chemically competent E. coli and plated overnight on LB agar containing 25
ug/mL AMP. Resulting colonies were analyzed by restriction digest and sequencing.
Drosophila S2 cells were transfected with AKH construct using calcium
phosphate transfection. Initially cultured cells were prepared for transfection by seeding
3 X 106 cells in a 35 mm plate in 3 mL complete media resulting in a final cell
concentration of 1 X 106 cells per mL. These cells were allowed to grow to a final cell
density of 3 X 106 cells per mL. Once the proper cell concentration was reached, solution
A was prepared to contain 240 mM CaCl2 and 19 ug recombinant DNA in a final volume
of 300 uL. Solution B was prepare to contain 300 uL 50 mM HEPES, 1.5 mM Na 2 HP0 4 ,
280 mM NaCl, pH 7.1. Solution A was slowly added to solution B dropwise with
constant mixing. The resulting solution was allowed to incubate at room temperature for
40 minutes allowing a precipitate to form. Finally, the solution was added dropwise to
the cells and allowed to incubate 24 hours at 28°C. The following day the calcium
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phosphate solution was removed from the cells and cells were allowed to incubate in
complete media. In 1 to 2 days copper sulfate was added in a final concentration of 500
uM and allowed to incubate for 4 days. To the production of a stable cell line, the AKH
construct was co-transfected with 1 ug pCoHygro vector (Invitrogen) providing the cells
with hygromycin resistance. Incubation in complete media for 3 to 4 weeks following
transfection was required prior to induction with copper sulfate.

Cloning and expression of human Gonadotropin-releasing Hormone
A synthetic DNA construct for the human gonadotropin-releasing hormone
(GnRH) was developed to contain the coding sequence for the final translation product of
human GnRH and a Drosophila secretion signal by overlap extension PCR. Overlap
extension PCR requires the combination of two primers which contain a minimum of 18
nucleotide complementary regions allowing the production double-stranded DNA. The
two primers used in the PCR reaction were 5'TTATCCAGGGCGCAGTCCATAGGACCAGTGCTGCCCGAGCGAGAGGCCAACA
AAGGCCAC-3' and 5'AATATGAAGTTATGCATATTACTGGCCGTCGTGGCCTTTGTTGGCCTCTCGCT
CGGG-3'. Touchdown PCR was utilized using annealing temperatures from 74°C to
60°C. Resulting PCR product was cloned into pMT/V5-His-TOPO vector. All
subsequent reactions followed the same protocol as the Drosophila AKH construct
analysis and expression in Drosophila S2 cells.

Heterologous Protein Expression in Bacterial Expression Systems
Cloning, expression, and purification of Drosophila glutaminyl cyclase
The putative Drosophila glutaminyl cyclase (QC) was identified by BLAST
searching using the human QC protein sequence. Two putative sequences with greater
than 60% sequence identity were identified. The gene with the highest sequence identity
was chosen for expression studies. A cDNA vector from Berkeley Drosophila Genome
Project (RE61650) was obtained containing gene CG5976.
PCR amplification of the putative QC gene from the cDNA vector used primers
5'-CACCCTGGTGGATATTCCTAAGATATCCTACA-3' and 5'CTACTTGGCCTCGGTTCC-3'. PCR reactions required an annealing temperature of
55°C and utilized 2.5 U Pfx proofreading polymerase. PCR product was inserted into the
pET160/GW/D-TOPO vector (Invitrogen) under TOPO cloning standard conditions.
PCR product was combined with pET160/GW/D-TOPO vector and concentrated salt
solution for a 5 minute incubation at room temperature. Resulting reaction was
transformed into One Shot chemically competent TOP 10 E. coli cells and plated on LB
agar containing 25 ug/mL AMP. Transformants were analyzed by restriction digest and
sequencing. Correct Drosophila QC (dQC) colonies were purified using Qiagen miniprep spin columns and maintained for further reactions.
Expression of the Drosophila QC required the transformation of One Shot
chemically competent BL21 cells (Invitrogen). A 10 mL overnight LB culture containing
25 ug/mL AMP was inoculated with BL21 cells containing the dQC vector, and was used
to inoculate 2-250 mL LB cultures containing 25 ug/mL AMP. The large cultures were
allowed to grow to mid-log phase at 37°C and then induced with 0.1 mM IPTG for 3
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hours at room temperature. Cells were collected by centrifugation at 3,000 x g for 10
minutes at 4°C. The resulting pellet was either frozen at -80°C overnight or immediately
used for purification.
Purification utilized the expressed poly-His tag. Pelleted cells were resuspended
in 30 mL 20 mM Tris pH 7.5,1 mM PTSF. Sonication of the cells on ice in three 30
second bursts on ice resulted in cell lysis. Cell lysate was then clarified by centrifugation
at 10,000 x g for 10 minutes at 4°C to pellet all insoluble material. The supernatant was
loaded onto 3 mL Ni-NTA resin (Invitrogen) in batch and allowed to bind with gentle
agitation at 4°C for 1 hour. Following binding the flow through was removed and the
resin was washed in batch. The resin was allowed to settle by centrifugation at 100 x g in
a swinging bucket centrifuge for 3 minutes. Removal of the flow through was followed
by addition of 30 mL 20 mM Tris pH 7.5, 500 mM NaCl, 20 mM imidazole. Resin was
centrifiiged, supernatant removed, and the wash step repeated two subsequent times.
Two wash steps with 30 mL 20 mM Tris pH 7.5, 500 mM NaCl, 50 mM imidazole and
one wash step with 30 mL 20 mM Tris pH 7.5, 50 mM imidazole followed. Finally, the
resin was placed in a disposable column and allowed to settle. The Drosophila QC
(dQC) was eluted in 1 mL fractions with 20 mM Tris pH 7.5,250 mM imidazole.
Fractions were visualized on the gel and stained with the lumio reagent to determine the
location of eluted dQC. The dQC was dialyzed against 50 mM MOPS pH 7.5 for
subsequent enzyme assays.
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Kinetic analyses of Drosophila glutaminyl cyclase
Activity of dQC was verified using both the spectrophotometric and fiuorometric
assays described above. Initially, QC activity was verified by using the basic
spectrophotometric assay at various time points and using various substrates.
To evaluate the kinetics of the expressed dQC assays utilizing substrates ranging
from 2 mM to 14 mM for Gln-NH2 and Gln-tBE were used in the spectrophotmetric
assay. Protocol described above was slightly altered to eliminate error in calculations.
Assay cocktail was prepared in V% amount of buffer and only 50 uL was used in each
assay tube. The substrates were prepared to add a total of 50 uL to each assay tube
providing the correct final substrate concentration. Kinetic constants were determined by
plotting the resulting velocities and substrates on Michaelis-Menton plots using
Kaliedograph.
Fiuorometric kinetics were determined similarly with substrate concentrations
ranging from 20 uM to 200 uM for Gln-PNA.

Cloning, expression, and purification of Drosophila glutaminyl cyclase-like protein
To evaluate the function of the other potential Drosophila QC identified by
original BLAST searches, another cDNA vector was obtained from Berkeley Drosophila
Genome Project (GH11174) containing gene CG32412.
The same protocol was used to clone the dQC-LK gene into the pET160/GW/DTOPO vector. Primers used were 5'-CACCATCGGTTCCGTAGTTTTTG-3' and 5'CTATGTTCGGTAAAAACGCA-3'. Initial expression results for the dQC-LKTOpo
revealed the majority of heterologous protein was located in the insoluble fraction.
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Attempts at expressing for longer periods of time at lower IPTG concentrations and
inducing at lower temperatures resulted in slightly better results but attempts were
unsuccessful at forcing an adequate fraction of the protein into the soluble fraction.
Therefore, an alternative expression system was chosen.
Expression of the dQC-LK protein was successfully completed using the
IMPACT system (NEB). Drosophila QC-LK was amplified from the cDNA clone using
primers 5'-TACTATACATATGATCGGTTCCGTAGTTTTTG-3' and 5'TACTATAGCAGGAAGAGCCTGTTCGGTAAAAACGCAA-3'. Primers were
designed with Ndel and Sapl restriction sites for subsequent enzymatic reactions. PCR
reaction required a single annealing temperature of 50°C and 2.5 U Pfx proofreading
polymerase. The resulting 1100 bp band was purified from the PCR reaction using the
GeneClean Turbo kit from QBiogene. One micrgram of the PCR product and 1 ug vector
pTXBl were digested for 1 hour at 37°C with Ndel and Sapl. Using the ratio of 0.89 ng
insert to 1 ng vector, the digested fragments were ligated overnight at 16°C. Ligation
reaction was transformed into OneShot TOP 10 chemically competent cells (Invitrogen)
and plated on LB containing 25 ug/mL AMP. Resulting colonies were screened for dQCLK insert using restriction digestion and sequencing.
The verified dQC-LKiMPACT clones were transformed into OneShot chemically
competent BL21 cells (Invitrogen) for expression. Ten mL overnight LB cultures
containing 25 ug/mL AMP were inoculated with the vector. Two 250 mL LB cultures
containing 25 ug/mL AMP were inoculated with the overnight culture and allowed to
grow to mid-log phase at 37°C. Temperature was lowered to 25°C and the cells were
induced by addition of 0.4 mM IPTG for 3 hours. Cells were collected by centrifugation
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at 3,000 x g for 10 minutes at 4°C. Cells were either frozen at -80°C or used immediately
for purification.
Purification of the dQC-LKiMPACT clones required a chitin column (NEB). Cell
pellet was resuspended in 100 mL 20 mM Tris pH 7.8, 500 mM NaCl, 1 mM PTSF.
Cells were sonicated on ice in three 30 second bursts. Cell lysate was centrifuged at
15,000 x g for 10 minutes to pellet cell debris. Supernatant was applied to 10 mL chitin
column prewashed with 10 bed volumes 20 mM Tris pH 7.8, 500 mM NaCl. Column
was then washed with 20 bed volumes 20 mM Tris pH 7.8, 1 M NaCl. Three bed
volumes of 20 mM Tris pH 7.8, 50 mM DTT was added to the resin. The column was
then stopped and allowed to incubate overnight at 4°C. The following morning, the
column was eluted with 20 mM Tris pH 7.8, 500 mM NaCl. SDS-PAGE and coomassie
staining were used to evaluate the purification of dQC-LK protein. The heterologous
protein was dialyzed overnight against 50 mM MOPS pH 7.5 for subsequent enzymatic
assays.

Testing aminopeptidase activity
The aminopeptidase activity of hQC (expression system designed by Temple),
dQC and dQC-LK was analyzed using the p-nitroanilide aminopeptidase assay described
above using 0.1 mM leu-pNA, 0.1 mM ala-pNA, and 0.1 mM gly-pNA as substrates.
The assays were completed for different time points, at different pHs ranging from 6.5 to
8.5, and zinc and cobalt concentrations ranging from 0 to 0.1 mM. Assays were run
using the microtiter plate reader with buffer and substrate as well as buffer and enzyme

blanks as negative controls. Leucine aminopeptidase (Sigma) was used as a positive
control in all assays.

Testing effect of leucine derivatives on QC activity
Effect of leucine and various leucine derivatives were tested as inhibitors of hQC
and dQC. Inhibitors tested include leucine, leucine-NH2, leu-gly, leu-ala, leu-leu, and
leucine chloromethyl ketone (leu CMK). Inhibition testing utilized the flurometric assay
under standard conditions as describes previously with the addition of inhibitor tested. Ki
determination utilized the spectrophotometric assay with final concentrations of leucine
peptides ranging from 0.25 mM to 5 mM. Effect of leu CMK was evaluated using the
spectrophotometric assay. These assays utilized timed preincubation of the QC tested
with various concentration of leu CMK along with a QC and buffer control. Following
the predetermined preincubation time, the cocktail was added and the typical assay
described above was completed.

Analyses of Native Drosophila Glutaminyl Cyclase
Antibody screening of crude Drosophila melanogaster extracts
Wild type adult Drosophila melanogaster were obtained to evaluate the presence
of a signal using human QC antibodies. Three different antibodies were used for all
cytochemistry studies. One antibody obtained from Novus Biologicals was developed
against a truncated portion of the hQC-GST construct previously expressed. Two other
antibodies were developed previously in the lab against a highly conserved portion of the
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amino acid sequence of QC. Table 3 summarizes the antibodies used throughout
experiments including antibody epitope, company, and antibody source.

Table 3: QC Antibodies.
Antibody
Name
Polyclonal
5247
5248

Antibody
type
Commercial
polyclonal
Anti-peptide
Anti-peptide

Epitope

Company

Truncated hQC-GST
Novus
construct protein
Biologicals
CHYDSKYFPHWDDRV
CHYDSKYFPHWDDRV

Antibody
source
Mouse
Rabbit
Rabbit

Drosophila crude extracts were developed by flash freezing adult Drosophila
melanogaster in liquid nitrogen for three 10 second freezes. Frozen flies were manually
grinded to a fine powder. The powder was suspended in 100 mM Tris pH 7.5, 150 mM
NaCl, 0.2 mM EDTA, 0.3 M sucrose, 1 mM PTSF and homogenized. The homogenate
was centrifuged at 3000 rpm for 5 minutes to pellet cell debris and nuclear pellet. The
supernatant was transferred to a fresh tube and centrifuged at 15,000 rpm for 30 minutes
to separate the cytosolic and membrane fractions. Both fractions were separated using
SDS-PAGE and transferred to nitrocellulose membrane for blotting.

Peptide antibody affinity purification
Previously prepared peptide antibodies 5247 and 5248 were purified using affinity
chromatography. Affinity resin was prepared by coupling hQC-GST and the protein
containing the peptide used for antibody production to a carbonyldiimidazole-activated
resin. CDI-activated resins contain a reactive carbonyl diimidazole which covalently
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attach to proteins via the amine group. For the coupling reaction, 5 mg hQC-GST in 50
mM borate pH 9.5 was placed on 1 mL prepared resin and allowed to bind overnight with
gentle agitation in the cold room. After coupling 50 mM Tris pH 9.5 was added to block
remaining reactive groups. After equilibration with PBS, the antibody serum was applied
to resin and allowed to couple for 1 hour with gentle agitation in the cold room. The
resin was washed with 5 bed volumes PBS and eluted in 0.5 mL fractions with 50 mM
glycine pH 2. pH was immediately neutralized with Tris base. Purified antibody were
used at a dilution of 1/500.

Production of Drosophila melanogaster PC mutants
Drosophila melanogaster QC mutants were obtained from Bloomington
Drosophila Stock Center at Indiana University. Mutants were deficient in Chromosome
III region 64 and balanced with TM6B-Tb1, a mutation marker which produces a tubby
phenotype. Tubby phenotype was used to verify the presence of mutation. Flies were
expanded for 15 days until a larger density was reached. At the 15 day point, virgin
females (genotype: def/TM6B-Tb1) were phenotypically selected and crossed with male
(genotype: TM3-Sb-LacZ/TM6B-Tb1). The genotype TM3-Sb-LacZ is a commonly used
mutation marker for the third chromosome. Resulting stubble phenotype was used to
verify the presence of properly crossed flies (genotype: def/TM3-Sb-LacZ) within the
progeny. Table 4 summaries all genetic crosses completed to produce the mutant fly line.
This table represents important genotype and phenotypes associated with QC deficiency
cell lines used during double mutant selection. Only genotype maintained after cross is
listed.
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Table 4: Important Fly Line Genotype/Phenotype
Fly Type
Virgin females
Crossing males
Progeny flies

Phenotype

Deficiency
present

Tubby - larvae are short, fat
Stubble - shorter hairs
Stubble - shorter hairs

+

Genotype
def/ TM6B-1V
TM3-Sb-LacZ/TM6B-TbI
def/TM3-Sb-LacZ

-

+

Collection and preparation of Drosophila embryos
Oregon R (or) strains of Drosophila were used as wild-type in all experiments.
Drosophila adults were maintained in cages on grape juice plates for 4 hours. Plates
were collected at 4 hours and aged to either 0-4 hours, 4-8 hours, 8-12 hours, 12-16
hours, 16-20 hours, and 16-24 hours before collection. Once the appropriate time had
passed, the embryos were collected following standard protocols. Collection included
removal of the chorion, outer membrane, with a 50% bleach wash for 3 minutes followed
by a 2 minute wash of 2 mL formaldehyde and 2 mL heptane. Lower formaldehyde layer
was removed and 6-10 mL methanol was added. The test tubes containing embryos were
shaken vigorously for 2 minutes. Embryos, now on bottom of tube due to loss of
membranes and fatty components, were placed in a 1.5 mL eppendorf tube and washed
5X with 1 mL methanol. Embryos were stored for up to 1 month in 1 mL methanol.

Immunocytochemistry of Drosophila embryos
Roughly 30 - 50 uL prepared embryos were utilized per reaction tube. The
storage methanol was removed and the embryos were washed with 1 mL PTX for 10
minutes while shaking. The PTX was removed and the wash was repeated for 20 minutes
while shaking. Next the embryos were washed with 1 mL of PBT one time for 10
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minutes and 6 times for 5 minutes while shaking. Next, 300 uL of the primary antibody
was added the embryos and the embryos were incubated at room temperature on their
side for 2 hours. To remove primary antibody, the embryos were washed 3 times with 1
mL of PBT for 10 minutes, and then 300 uL of the secondary antibody was added.
Embryos were incubated again at room temperature for 2 hours on their side. Next,
embryos were washed 6 times for 10 minutes each with 1 mL PBT. During the washes,
the Avidin-Horseradish peroxidase solution was prepared at a 1:100 dilution of each in
PBT and allowed to incubate in the dark for 30 minutes. Three hundred microliters of the
solution was added to each reaction tube and allowed to incubate at room temperature for
30 minutes wrapped in foil. Embryos are washed twice with 1 mL of PBT for 5 minutes
per wash followed by two 10 minute washes using 1 mL of PTX. The peroxidase
reaction is then developed by adding 270 uL of peroxidase substrate and 30 uL of DAB
to the embryos. The staining is monitored through a dissection microscope. Embryos are
placed in PTX and washed. For double staining, the procedure is repeated using new
antibodies against the LacZ protein used as a marker in mutants.

RNA in situ methods
Using the QC (RE61650) and QC-LK (ghl 1174) cDNA vectors used for protein
expression, RNA in situ probes were developed. The probes were designed to contain a
T7 promoter site for subsequent reactions. Both antisense and sense strands were
amplified to provide both experimental conditions and control conditions. Table 5
provides the sequences of the sense and antisense primers used to develop probes in the
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study. Initial PCR reaction used the following primers in with typical PCR conditions
and annealing temperatures of 55°C for dQC and 57°C for dQC-LK.

Table 5: In situ Hybridization Primers.
Forward dQC antisense: ATGCGTCTGCTACTCAGAAATTATTC
Reverse dQC antisense: TAATACGACTCACTATAGGGAGACTACTTGGCCTCGGTTCC
Forward dQC sense: TAATACGACTCACTATAGGGAGAATGCGTCTGCTACTCAGAAATTATTC
Reverse dQC sense: CTACTTGGCCTCGGTTCC
Forward dQC-LK antisense: ATGGCGATCGGTTCCGTAC
Reverse dQC-LK antisense: TAATACGACTCACTATAGGGAGACGACAATTCACTGGTGACGTG
Forward dQC-LK sense: TAATACGACTCACTATAGGGAGAATGGCGATCGGTTCCGTAC
Reverse dQC-LK sense: CGCAAATCCACTGGTGACGTG

Once DNA was amplified to contain the T7 promoter site, it was cleaned using a
GENECLEAN turbo purification kit. To complete the transcription reaction the
MEGAscript T7 transcription kit (Ambion) was used. Briefly, the DNA product was
combined withNTP mixture, 10X reaction buffer containing T7 RNA polymerase, and
3.5 mM DIG-UTP (Roche) and incubated at 37°C for 3 hours. TURBO DNase (Ambion)
was added to reaction and allowed to incubate at 37°C for an additional 15 minutes.
Product was recovered using MEGAclear Kit (Ambion). RNA was quantified for
following studies.
Fixed embryos were placed in an eppendorf tube and rinsed with PTX 3 times.
Next, embryos were rocked for 10 minutes at room temperature in 50:50 hybridization
solution:PTX followed by a 2 minute rinse in hybridization solution. Embryos are then
pre-hybridized for 1 - 2 hours in 1 mL hybridization solution at 55°C. During prehybridization the probes are prepared by adding approximately 500 ug probe for 100 uL
hybridization solution, heating to 80°C for 3 - 5 minutes, and then placing on ice. Once
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the pre-hybridization solution is removed the probe is added to the embryos and allowed
to sit at 55°C for 2 - 4 days. Next the hybridization solution plus probe is discarded and
the embryos are washed 4 times for 15 minutes, 2 times for 30 minutes, and allowed to
stand overnight at 55°C in hybridization solution. The embryos are then washed for 20
minutes rocking at room temperature in hybridization solution: PTX in the dilution 3:1,
1:1, and 1:3. The embryos are then washed 5 times in PTX for about 10 minutes each.
Pre-adsorbed anti-DIG antibodies are diluted 1:2000 over embryos and allowed to
incubate overnight at 4°C. Finally, the anti-DIG antibody solution is removed, the
embryos are washed 4 times for 20 minutes in PTX at room temperature, and then
exposed to NBT/BCIP for approximately 10-40 minutes in the dark. Embryos are
viewed under microscope for analysis.

Analyses of Native Mammalian Glutaminyl Cyclase
Antibody screening of mouse tissues
Mouse customized tissue blot containing 7 days old adrenal, 0 days old brain, 7
days old brain, 7 days old cerebellum, 7 days old cerebrum, 7 days old thymus, 7 days
old skin, 7 days old eye, and whole fetus was obtained from ProSci, Inc. Tissue blot was
developed using both a 1/2000 dilution of polyclonal antibody, 1/10000 dilution of antimouse secondary antibody, and developed with NBT/BCIP. Tissue blots were stripped
using a standard protocol. The blot was incubated in a sealed plastic container at 50°C
for 30 minutes in a solution of 100 mM 2-mercapoethanol, 2% SDS, 62.5 mM Tris-HCl,
pH 6.7. The blot was rinsed with WBS and reprobed as usual. The tissue blot was
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developed again using a 1/500 dilution of purified peptide antibody 5247, 1/10000
dilution of anti-rabbit secondary antibody, and developed with NBT/BCIP.

Computer Predictions and Phylogenetic Analyses
Property Predictions oiDrosophila QCs
Various prediction programs were used to determine properties of the expressed
proteins. Amino acid sequences were obtained from the NCBI databank. The following
programs located in the ExPASy Proteomics Tools were used to predict the properties of
both Drosophila QC isoforms by inserting the amino acid sequences into the program.
TargetP was used to predict the subcellular localizations of all proteins. All predictions
utilized the protein sequences with predicted signal sequences removed once the signals
were predicted using TargetP. Physical properties were predicted using ProtParam
program. Glycosylation site predictions utilized the program NetNGlyc.

Development of Phylogenetic Trees
Development of Phylogenetic trees utilized the program PhyloDraw. Sequences
were obtained from the NCBI website by completing BLAST searches with the human
QC as the source sequence. All sequences were then aligned based on either sequence
similarity or tertiary structure similarity. Aligned sequences were imported into the
PhyloDraw program and used to develop trees based on either sequence conservation or
tertiary structure conservation.

CHAPTER III
RESULTS

Peptide Hormone Expression in Drosophila Schneider 2 (S2) Cells
Cloning and Expression of Drosophila Adipokinetic Hormone (AKH)
Amplification of the Drosophila AKH from Drosophila S2 cells resulted in a 400
bp band utilized for subsequent cloning. Analysis of positive clones was initially
confirmed by restriction digestion using EcoRI and NotI providing a 3.7 kb and a 300 bp
band and followed by sequencing.
The pMT/V5-His-TOPO containing the AKH gene was transiently transfected
into Drosophila S2 cells using the standard calcium phosphate transfection protocol. A
parallel transfection with pMT/V5-His-TOPO (no insert) was used as a negative control.
Samples collected were analyzed by SDS-PAGE. It was initially determined the
relatively small amount of protein product possibly produced would not be sufficient to
observe over all contaminating proteins in the serum media. Therefore, stable
transfections were completed to produce larger cultures. SDS-PAGE gels still
demonstrated a large amount of contaminating proteins possibly masking the production
of the AKH. Figure 12 is an example of a gel observing the banding pattern of the
contaminating proteins.
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Figure 12: AKH Serum Media Expression Results. Lane 12 contains a
polypeptide standard. Lane 11-7 contains a control lane of blank vector pMT/V5-HisTOPO induced with copper sulfate in 1 day increments. Lane 6 contains the zero time
point expression vector induced with copper sulfate. Lanes 5-1 represent 1 day
increments in expression time course. Small bands were observed in lanes 5-1 suggesting
expression of the AKH but the serum media contained too much contamination.

Cells were adapted to grow under serum free conditions due to the high levels of
protein contamination in media samples. Though the protein amounts were decreased in
the media, protein production from non-transfected cells in controls produced multiple
bands when visualized by SDS-PAGE. Therefore, it was concluded the protein could not
be produced without the presence of contaminating proteins in transiently transfected cell
lines. Figure 13 demonstrates the banding pattern observed during AKH production in
serum-free media.
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Figure 13: AKH Serum-free Media Expression Results. Lane 1 contains a
polypeptide standard. Lane 2 contains a control lane of blank vector pMT/V5-His-TOPO
induced with copper sulfate for 1 day. Lane 3 contains the zero time point expression
vector induced with copper sulfate. Lanes 4-8 represent 1 day increments in expression
time course. Large bands present in lanes 4-8 are too large to represent AKH. The same
bands are observed in control expression for longer time points.

Inductions of stable cell lines, both serum and serum-free cultures, resulted in cell
death. Upon addition of various Q1SO4 concentrations, cells were no longer viable when
viewed using tryphan blue staining. Cell death resulted in production of no protein
product.
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Cloning and expression of Human Gonadotropin-releasing Hormone (GnRH)
Human GnRH was designed synthetically containing the mature GnRH sequence
and a self-cleaving BiP secretion signal. Positive clones were identified using restriction
digestion by Aval resulting in 700 bp, 1100 bp, and 1800 bp bands.
Similar protocols were followed for expression in S2 cells. SDS-PAGE analyses
of the transfected cell media resulted in similar banding patterns observed in the AKH
transfection experiments. Induction of peptide hormone production in stable cell lines
resulted in cell death.

Expression of Drosophila Glutaminyl Cyclase (dQC)
Drosophila QC coding region amplification from the cDNA vector RE61650
resulted in DNA fragments of approximately 1100 bp, which were subcloned in the
bacterial expression vector, pET160/GW/D-TOPO. The pET160/GW/D-TOPO vector
contained an inducible promoter, lac operon, an N-terminal polyhisitidine (poly-His) tag
for purification, and an N-terminal Lumio® tag enabling in-gel fluorescent protein
detection. Figure 14 diplays a diagram of the expression vector.
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Figure 14: pET160/GW/D-TOPO expression vector. This figure represents the
vector map of the pET160/GW/D-TOPO used for subcloning the dQC.

Recombinants were screened for presence of PCR inserts in the correct
orientation by restriction digests using Aval. Aval cuts the expression vector containing
the Drosophila QC (6805 bp) insert resulting in two fragments 2637 bp and 4168 bp in
length. Incorrect orientation of the insert would have resulted in fragments 1671 bp and
5134 bp in length. Figure 15 displays the restriction digest. Colony 5 was selected for
expression protocols and the insert was verified by sequencing. Sequencing results
verified the correct construct was produced with no incorrect substitutions during PCR.
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Figure 15: Confirmation of dQC vector. Lane 1 contains the 1Kb ladder. Lanes
2 through 7 contain colonies 1-6 digested with Aval. Lane 6 contains colony 5 which has
bands in the correct locations of 2637 bp and 4168 bp.

The pilot expression, shown in figure 16, was completed to examine the
production of protein. The pET160/GWZD-TOPO with the dQC insert produces a fusion
protein which is composed of the amino terminal poly-His tag and Lumio tag (6.7 kD)
combined with the dQC (36.8 kD). Therefore, expected size of the dQC protein is 44 kD.
Initial expression of dQC at various time points and temperatures in the presence of 0.1
mM IPTG resulted in production of an approximately 44 kD protein as evidenced by
SDS-PAGE. It was determined the optimum expression temperature was 25°C and the
optimal time for induction was 4 hours.
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Figure 16: Expression Profile of dQCPET- Lane 1 represents a protein standard.
Lanes 2 - 5 represent dQC expression at 25°C for time points 0 hours, 4 hours, and 8
hours, and 4 hours (control). Lanes 6 - 9 represent dQC expression at 30°C for time
points 0 hours, 4 hours, and 8 hours, and 4 hours (control). Lanes 1 0 - 1 2 represent dQC
expression at 37°C for time points 0 hours, 4 hours, and 4 hours (control). Gel was
visualized using the Lumio detection tag.

Initial attempts at Ni-NTA purification resulted in impure dQC enzyme.
Therefore, optimization was completed using varying concentrations of salt and
imidazole in wash buffers and elution buffers. Final purification using 10 mM imidazole
and 50 mM imidazole sequential wash steps and 250 mM imidazole elution resulted in a
pure protein of approximately 44 kD. SDS-PAGE gels of the dQC purification stained
with coomassie blue and developed using the Lumio detection reagent are shown in
figure 17.
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Figure 17: Purification of expressed Drosophila QC. 10% Tricine gel of NiNTA resin purification of expressed Drosophila QC. The figure to the left is stained with
Simply Blue safestain (Invitrogen). The figure to the right is developed using the Lumio
reagent (Invitrogen). Lane 1 contains a Precision Plus Protein standard (BioRad) with
intense bands corresponding to 25kD, 55kD, and 75kD. Lanes 2-6 represent wash
fractions and lanes 7 - 1 0 represent elution fractions exposed to 250 mM imidazole. For
analysis, fractions 8 - 9 were pooled.

The Drosophila QC sequence was verified through specific sequence analyses
using trypsin digest and MALDI-TOF. MALDI spectra resulted in a mass list
corresponding to the predicted Drosophila QC sequence with a likelihood of greater than
70%. Further verification utilized MS-MS on various selected trypsin digest peaks.
These results demonstrated the actual sequence of selected peaks which corresponded to
the predicted dQC sequence. The smaller, 25 kD, band observed on purification gels was
also verified as a degradation product by MALDI-TOF analysis corresponding to
digestion at the trypsin site lysine 222.
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Another dQC expression system was explored using the glutathione-S-transferase
(GST) system previously used to express the human QC. The same dQC cDNA product
used in production of the dQC-pET vector was subjected to a restriction digest and
ligated into the GST vector. Following analyses for correct insertion and orientation the
dQC vector was transformed into BL21 E. coli cells. The dQC protein was produced in
the insoluble fraction. Therefore, the dQC could not be easily used for enzymatic
analyses and was stored for later use.

Characterization of dQC
Purified dQC was checked for QC activity using the spectrophotometric and
fluorometric assays. Initial results demonstrated QC activity using both Gln-NH2 and
Gln-tBE substrates in a time dependent manner. Enzyme activity was tested in the
presence of known QC inhibitors imidazole, 1-methyl imidazole, and 1-10
phenanthroline. Drosophila QC was inhibited in the same manner as human QC
suggesting the expressed peptide was a QC. Optimum assay pH was determined to be
7.5.
Kinetic analyses revealed virtually identical kinetic values for the expressed
Drosophila QC when compared with published human QC values on all tested substrates.
The Km values for spectrophotometric assay substrates Gln-NH2 and Gln-tBE were 1.4 ±
0.4 mM and 6.6 ± 0.6 mM, respectively. The Km value for the fluorometric assay
substrate Gln-pNA was 42 ± 5 uM. Table 6 provides a comparison of the values for dQC
compared to the previously determined values for human QC. (*Booth 2003)

The kcat and kcat/Km values for the Drosophila QC are, however, much lower
than the values for human QC demonstrating the expressed Drosophila QC has a lower
turnover. Therefore, the dQC appears to be less efficient than the human QC. In order to
determine if the enzyme activity was altered in the purification procedure, various
changes were made to the protocol such as temperature, pH, ionic strength, etc. resulting
in similar kinetic values. Therefore, it is possible that the lower enzyme activity is a
natural characteristic but it is most likely due to the harsh conditions necessary for
heterologous protein purification which can not be altered.

Table 6: Kinetic parameters for the expressed Drosophila QC.
Substrate

Enzyme
Type

Km
(mM)

kcat

Or )

(mM'V1)

Drosophila QC

1.4+/-0.4

1.7+/-0.2

1.2+/-0.2

*Human QC

1.4+/-0.2

13

9.3

Drosophila QC

6.6 +/- 0.6

2.6 +/- 0.2

0.4 +/- 0.06

6.7 +/- 2

16.0

2.4

1.9+/-0.3

45 +/- 3

1

kcat/Km

Gln-NH2

Gln-tBE

*Human QC
Gln-pNA

Drosophila QC 0.042 +/- 0.005
*Human QC

0.060 +/- 0.006 18.8+/-0.7
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Inhibition studies revealed the Drosophila QC was inhibited by imidazole,
imidazole derivations such as 1-methyl imidazole, and metal chelators such as 1-10
phenanthroline. Determination of Ki values revealed essentially equal values when

compared to human QC. The Ki was evaluated for 1-methyl imidazole as 0.02 ± 0.01
mM, which is essentially equal to the Ki for human QC. This suggests the Drosophila
QC and human QC have similar modes of inhibition with respect to the tested inhibitors.
Figure 18 displays graphically the inhibition of dQC by imidazole, imidazole derivatives,
and metal chelators.
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Drosophila QC activity in presence of inhibitors

1: No inhibitor
2: imidazole
3: 1-methyl imidazole
4: 1,10-phenathroline

Dixon plot: Ki methyl imidazole using 2 substrate concentrations
46

• 3mM Gln-NH2
• 9mM Gln-NH2
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Figure 18: Inhibition profile of dQC. The column graph represents the
inhibition profile of dQC. Column 1 represents uninhibited dQC in a 30 minute assay,
column 2 represents inhibition by imidazole, column 3 represents inhibition by 1-methyl
imidazole, and column 4 represents inhibition by 1,10-phenanthroline. This suggests
dQC is inhibited in the same manner as hQC. The line graph to the left represents a
Dixon plot of dQC inhibition by 1-methyl imidazole. The Ki was calculated at 0.02 mM
+/-0.01. Error is calculated from 3 runs of the same experiment. TheKiofl-methyl
imidazole with hQC is 0.03 mM.
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Human QC has previously been purified using a reactive blue column
demonstrating the ability of the human QC to bind the reactive blue. Attempts to
demonstrate the binding of dQC to the reactive blue column revealed a similar binding
pattern. As with hQC, the dQC was eluted from the column at a high pH of 8.5. This
demonstrates a similar 3-D orientation of the dQC and the human QC.

Expression of Drosophila Glutaminyl Cyclase-Like (dQC-LK)
The Drosophila QC-LK coding region was amplified from the cDNA vector
GH11174 resulting in a band of approximately 950 bp. The PCR product was directly
subcloned into pET160/GW/D-TOPO (Invitrogen) for bacterial expression.
Recombinants were screened for presence of PCR inserts in the correct orientation by
restriction digests using Aval and Notl. Aval cxxt the expression vector containing the
Drosophila QC-LK (6754 bp) insert resulting in three fragments 804 bp, 2499 bp, and
3451 bp in length. Incorrect orientation of the insert would have resulted in fragments
135 bp, 2499, and 4120 bp in length. All 4 colonies tested appeared to be in the correct
orientation (figure 19). Colony 1 was selected for expression protocols and the insert was
verified by sequencing. Sequencing results verified the correct construct was produced
with no incorrect substitutions during PCR.
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Figure 19: Confirmation of dQC-LK vector. Lane 1 contains the 1Kb ladder.
Lanes 2 through 5 contain colonies 1-4 digested with Aval and Notl. Lane 6 contains the
100 bp ladder. All lanes appear to be in the correct orientation.

The pilot expression was completed to examine the production of protein. The
pET160/GW/D-TOPO produces a fusion protein which is composed of the amino
terminal poly-His tag and Lumio tag (6.7 kD) combined with the dQC-LK (40 kD).
Therefore, the expected size of dQC-LK protein is 47 kD. Initial expression of dQC-LK
at 25°C for 3 hours in the presence of 0.1 mM IPTG resulted in protein expression
primarily in the insoluble fraction. Small amounts of dQC-LK protein were observed at
approximately 47 kD but due to the low concentration a different expression vector was
used for expression studies, figure 20.

81

Figure 20: Expression of dQC-LKxopo- The figure represents a 10% Tricine gel
of the soluble dQC-LK expression. The bands demonstrate the small amount of dQC-LK
produced in the soluble fraction.

PCR amplification using specific primers resulted in a 1000 bp band sublcloned
into the expression vector, pTXBl (dQC-LKiMPAcr)- Resulting colonies were analyzed
by restriction digestion using Aval. Correct clones would result in fragments of 164 bp,
2167 bp, and 5404 bp. Clones containing an insert in the incorrect orientation would
result in fragments of 900 bp, 2167 bp, and 4641 bp. Colonies 1 and 6 appeared to
contain the insert in the correct orientation (figure 21). Both were verified by
sequencing.
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Figure 21: Confirmation of <1QC-LKIMPACT Vector. Lane 1 contains a 1 Kb
ladder, lanes 2 through 5 contain colonies 1, 5, 6, and 7, and lane 6 contains a 100 bp
ladder. Colonies 1 and 6 appear to contain a 5 Kb fragment which suggests the colonies
contain insert in the correct orientation.

Expression of the dQC-LKiMPAcr vector in BL21pLys expression cells revealed a
band of approximately 50 kD in the elution fractions. Elution bands were verified by
MALDI following in-gel trypsin digest. As with the dQC, MS-MS was used to further
verify the results. Figure 22 displays a SDS-PAGE gel of the dQC-LK purification
stained with coomassie blue.
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Figure 22: Purification of dQC-LKiMPAcr- Lane 1 contains a protein standard.
Lanes 2-3 represent the wash fractions. Lanes 5-7 represent 1 mL elution fractions. The
dQC-LK is located in all elution fractions.

The activity of the expressed dQC-LK was analyzed using the spectrophotometric
assay previously described. The dQC-LK showed similar but slightly lower activity
compared to the expressed dQC enzyme. Typical assays revealed 50 - 70 % of the
activity observed in the dQC when the same amounts of protein were added to each
enzyme assay. Figure 23 demonstrates the observed activity of purified hQC-GST,
dQCpET, and dQC-LKiMPAcr- Further analyses of the dQC-LK protein were completed by
a competitor before kinetics experiments were finalized. Competing published data
correlates to all results obtained.
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Figure 23: QC activity of hQC, dQC, and dQC-LK. This graph demonstrates
the absorbance change over 60 minutes using the spectrophotometric assay under
standard assay conditions. Errors are calculated from assays completed using three
different preparations of dQCPET and dQC-LKiMPAcr recombinant proteins. All assays
were completed at least 3 times.

Analysis of dQC and dQC-LK aminopeptidase activity
Due to the overall structural similarity observed between human QC and bacterial
aminopeptidase active site amino acids, the aminopeptidase ability of hQC, dQC, and
dQC-LK was tested using the p-nitroaniline aminopeptidase assay described. Briefly, pnitroaniline conjugated to various amino acids, typically leucine, was incubated with a
leucine aminopeptidase as a positive control or the QCs. Reaction conditions were varied
in pH and zinc concentrations. Glutamine conjugated p-nitroanilide is not commercially
available.
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Initial attempts to elicit aminopeptidase activity utilized the normal QC assay
buffer of 50 mM MOPS at pH 7.5 and 1 mM leucine p-nitroanilide as substrate with a
final zinc concentration of 0.1 mM. Initially, relatively small activity was observed in the
QC tests. Results demonstrated the QCs' aminopeptidase activity was approximately
10% of the commercially available leucine aminopeptidase activity from porcine kidney.
Aeromonas proteolytic aminopeptidase is not commercially available. Figure 24
demonstrates the results.
In all assays, controls containing substrate only and enzyme only were completed
to verify that absorbance observed was due to aminopeptidase activity and not substrate
breakdown. Analysis of controls for production of any absorbance was required due to
the small absorbance increase observed in the QC samples. Typically, any absorbance
observed in either the substrate only or enzyme only control was subtracted from the
tested samples containing both substrate and enzyme.
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Figure 24: Aminopeptidase Activity Test. This graph demonstrates the
aminopeptidase activity observed by aminopeptidase (AP), hQC, dQC, and dQC-LK.
The assay was completed at pH 7.5 using leucine p-nitroanilide as substrate. Standard
errors were calculated from 6 trials of experiments.

In an attempt to induce higher aminopeptidase activity, assay conditions were
altered. First, time courses were completed with various incubation times and it was
determined that four hour incubations were required to reach maximal aminopeptidase
activity in the QC tests. Various zinc concentrations ranging from 0 to 0.1 mM
demonstrated no effect on activity even in the positive controls. Therefore zinc was
omitted from the assays in further experiments. Out next attempt tested a pH range of 6.0
to 8.0 using a 30 mM MOPS, 30 mM MES mixture due to the differences in
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aminopeptidase and QC assay pH optima. The aminopeptidase is more active at a slighty
basic pH than QC which is more active around pH 7.2 - 7.5. Surprisingly, results
indicated the most aminopeptidase activity of the QC in the more acidic range at pH 6.5
while the aminopeptidase was most active at pH 7.5 and pH 8.0 as expected. Figure 25
demonstrates the results.
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Figure 25: Aminopeptidase Activity of QC at Various pHs. This bar graph
demonstrates the aminopeptidase activity observed by aminopeptidase (AP), hQC, dQC,
and dQC-LK at pH 6.0, 6.5, 7.0, 7.5, and 8.0. Standard errors were calculated from 6
trials of experiments.

Similar experiments were completed using alanine p-nitroanilide and glycine pnitroanilide. Both substrates revealed similar levels of aminopeptidase activity in QC
with the leucine p-nitroanilide substrate. However, the leucine p-nitroanilide resulted in
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the highest aminopeptidase activity and was used for all following assays. Finally, the
amount of QC added to the assay was increased 100-fold which resulted in a very slight
increase in aminopeptidase activity. Therefore, the results suggest only approximately 10
- 15 % aminopeptidase activity could be obtained from the hQC, dQC, or dQC-LK
compared to the commercially available leucine aminopeptidase.
Due to the apparent low levels of aminopeptidase activity of the QCs on leucine
p-nitroanilide, further testing was completed using various leucine peptides. The
aminopeptidase activity results suggested the QCs were capable of binding the leucine.
Therefore, commercially available leucine amide (leu-NH2), leucine-glycine (leu-gly),
leucine-alanine (leu-ala), and leucine-leucine (leu-leu) were tested as QC inhibitors.
Several leucine peptides demonstrated inhibition of hQC and dQC. At a
concentration of 1 mM, addition of leucine peptide resulted in a loss of activity
demonstrated in both the spectrophotometric and fluorometric assays. Figures 26 and 27
demonstrate typical results of hQC and dQC activity in the presence of all peptides.
However, no activity loss was observed in the presence of leu-NFk.
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Effect of Leu-Peptides on hQC Activity
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Figure 26: Inhibition of hQC with Leu-peptides. This graph demonstrates the
inhibition of hQC by leu-gly, leu-ala, and leu-leu using the fluorometric assay.
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Figure 27: Inhibition of dQC with Leu-peptides. This graph demonstrates the
inhibition of dQC by leu-gly, leu-ala, and leu-leu using the fluorometric assay.
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To further evaluate the inhibition of QC by leucine peptides, using hQC as
enzyme, inhibition data was plotted using both Dixon plots (figure 28) and LineweaverBurke plots (figure 29). Ki values were determined for leu-gly, leu-ala, and leu-leu from
the Dixon plots. The results are demonstrated in figure 28. The Ki values for leu-gly,
leu-ala, and leu-leu were calculated as 1.02 +/- 0.44 mM, 0.97 +/- 0.32 mM, and 0.47 +/0.33 mM, respectively. hQC was most strongly inhibited by leu-leu followed by leu-ala
and leu-gly. Since leucine did not inhibit hQC, these results suggest a larger group bound
to the leucine increases the inhibition. Both plots verify the leucine is a competitive
inhibitor binding to the enzyme active site.
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Dixon Plot: Determination of Ki with leu-gly
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Dixon Plot: Determination of Ki with leu-ala
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Figure 28: Dixon plots of leucine peptide inhibition. This figure demonstrates
the Dixon plots for hQC in the presence of leu-gly, leu-ala, and leu-leu. All graphs were
created as averages of a minimum of three experimental runs.
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Lineweaver-Burke Plot: Inhibition of hQC by leu-gly
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Figure 29: Lineweaver-Burke plots of leucine peptide inhibition. This figure
demonstrates the Lineweaver-Burke plots for hQC in the presence of leu-gly, leu-ala, and
leu-leu. All graphs were created as average of a minium of three experimental runs.
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Verification of the QC binding to leucine was further evaluated by testing the
effect of other di-peptides and leucine derivatives on the QC activity. Using similar
studies it was determined the enzymatic rate was unaffected by addition of ala-ala. This
suggests the enzyme is interacting specifically with the leucine. Competition
experiments using the common flurometric assay substrate, GlnpNA in a typical reaction,
with Leu|3NA added revealed a decrease in enzyme activity with both substrates added to
the assay reaction compared to a reaction containing just GlnpNA. This demonstrated the
ability of QC to bind leucine.
Further testing revealed a possible irreversible inhibition by another leucine
derivative, leucine chloromethyl ketone (leu CMK). Addition of 1 mM leuCMK to hQC
or dQC resulted in a time dependent loss of activity. Literature has demonstrated the
ability of Leu CMK to act as an affinity label in various enzymes containing an active site
histidine residue. After 30 minutes of enzyme preincubation with 1 mM leu CMK, 25%
of the hQC activity was lost and 45% of the dQC activity was lost. Results are shown in
figure 30. Due to the activity loss increase observed over time, the leu CMK serves as a
possible affinity label of QC. These results further demonstrate leucine binding of QC
and also the presence of a histidine residue within the active site.
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Figure 30: Activity Loss in Presence Leucine Chloromethyl Ketone. The top
figure displays the activity loss of hQC in the presence of 1 mM leuCMK. The bottom
graph displays the activity loss of dQC in the presence of 1 mM leuCMK.

Analyses of Native Drosophila Glutaminyl Cyclases
Initial experiments utilized the commercial polyclonal and monoclonal QC
antibody and previously developed peptide QC antibody. Antibody specificity was
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verified using expressed hQC, dQC, and dQC-LK. The polyclonal antibody specifically
binds the hQC and dQC recombinant enzymes but not the dQC-LK. The peptide
antibody specifically binds the hQC and dQC-LK recombinant enzymes. These results
were verified by competition experiments. However, the monoclonal antibody did not
bind either dQC or dQC-LK in the Western Blot analyses. Western blots demonstrating
the specificity of the two antibodies for each recombinant protein is shown in figure 31.
A single immunogenic band was observed in both Drosophila S2 cells and whole
Drosophila fly lysates using the polyclonal and peptide antibody. This band was
visualized by both the polyclonal and peptide antibody. It was approximately 75 kD in
size suggesting some post-translational modification occurs.
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Figure 31: Western Blot of Recombinant QC Enzymes. Image A represents a
western blot containing dQC in lane 2 and hQC in lane 3 developed with the commercial
polyclonal antibody diluted 1/2000. Lane 4 contained the dQC-LK recombinant protein
with no staining was observed. Image B represents a western blot containing hQC in lane
1, dQC in lane 2, and dQC-LK in lane 3 developed with the peptide antibody 5247
diluted 1/5000. Only the dQC-LK was detected with the peptide antibody.
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Immunocytochemistry ofDrosophila Embryos
Immunocytochemistry was used to localize both the dQC and dQC-LK proteins
within the wild type (Oregon R) and dQC-LK mutant Drosophila melanogaster embryos.
(For mutant production and genotype see methods) Following standard procedures, the
following results were obtained as shown in figure 32. The peptide antibody did not
produce any staining in the embryos. However, this is commonly observed in
Drosophila embryo immunocytochemistry. The polyclonal antibody, which is specific to
the dQC, revealed specificity for a protein in the hypopharynx region. The dQC-LK
mutant also showed the same specificity. Due to possible cross-reactivity of the dQC
isoforms, the immunocytochemistry results were not definitive. Definitive results would
require production of a dQC mutant and dQC/dQC-LK specific antibodies.

Figure 32: Polyclonal antibody staining of embryo. This image demonstrates
the staining of the hypopharynx region in the Drosophila embryo using the polyclonal
antibody. This embryo is a stage 13 embryo oriented anterior to posterior.

In situ Hybridization of Drosophila Embryos
In situ hybridization of Drosophila embryos was used to localize both the dQC
and dQC-LK RNA transcripts. Experiments utilized overnight embryo collections of
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wild-type (Oregon R) Drosophila melanogaster. Following standard procedures, the
following results were obtained. The dQC-LK RNA transcript was identified as early
maternal transcript throughout the entire embryo in stage 5. In later developmental stages
1 2 - 1 5 , the transcript was identified in the mesoderm, hypopharynx, gut, and in the
developing ventral nerve cord. Verification of the identification of dQC-LK in the nerve
cord was accomplished by a nerve cord dissection. All tracheal staining was considered
non-specific due to the presence of tracheal staining in sense controls. Tracheal staining
is typically observed due to RNA probe degradation. The dQC RNA transcript was
identified in very low amounts as maternal transcripts in stage 5 embryos and possibly in
epidermal tissues, including the hypopharynx, in later stages 12-15. Again, non-specific
tracheal staining was observed in both experimental antisense and control sense embryos.
The dQC-LK appears to be more diversely localized within the developing embryo and in
a higher quantity. Figures 3 3 - 3 5 demonstrate the in situ localization studies.
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Figure 33: RNA in situ using dQC-LK probe. (A) This figure contains stage 5
embryos demonstrating the staining of maternal transcript. (B) This figure contains stage
13 embryos with experimental on the left and control on the right. Arrow 1 indicates the
staining of the hypopharynx, arrow 2 indicates the gut, arrow 3 indicates the mesoderm,
and arrow 4 indicates the ventral nerve cord. The trachea is found in both the control and
experimental embryos. (C) This figure contains stage 15 embryos with experimental on
the left and control on the right. Arrow 1 indicates the staining of the hypopharynx,
arrow 2 indicates the gut, arrow 3 indicates the mesoderm, and arrow 4 indicates the
ventral nerve cord. The trachea is found in both the control and experimental embryos.
All embryos are oriented anterior-posterior with the ventral facing up.

Figure 34: RNA in situ using dQC probe. Stage 14 embryo demonstrating the
faint staining of the hypopharynx (1) and epidermis (2). The embryo is oriented anteriorposterior with the ventral facing up.

Figure 35: RNA in situ using dQC-LK probe nerve cord dissection. The
image to the left demonstrates a stage 14 embryo with the location of the ventral nerve
cord indicated. The image to the right demonstrates the staining in the dissected nerve
cord. The staining indicates no defined neuronal expression pattern. The pattern
suggests a vesicular pattern.
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Analyses of Native Mammalian Glutaminyl Cyclase
Immunostaining of commercial blots containing various tissues from fetal through
7 day old mice revealed the expression of QC in all tissues. However, unexpectedly, the
highest expression appeared in the skin and eye. Both commercial polyclonal antibody
and peptide antibody yielded a similar staining pattern. The Western blots are shown in
figure 36.

Figure 36: Immunocytochemistry of mouse QC. Commercial mouse blots
containing a protein standard in lane 1, lane 2 contains 7 days old adrenal, lane 3 contains
0 days old brain, lane 4 contains 7 days old brain, lane 5 contains 7 days old cerebellum,
lane 6 contains 7 days old thymus, lane 7 contains 7 days old skin, lane 8 contains 7 days
old eye, and lane 9 contains whole fetus. The red arrow indicates the band corresponding
to a size of approximately 37 kD, the predicted size of mouse QC.

CHAPTER IV
DISCUSSION

Expression of Drosophila AKH and Human GnRH Hormones
Expression of both the Drosophila AKH and human GnRH hormones in the
Drosophila S2 cell line resulted in cell death upon induction of hormone expression. The
production of peptide hormones at specific times in the cell is used as a signal to exert a
specified function. Sudden induction of large amounts of the hormones during normal
cellular activity could have traumatized the cells in culture resulting in cell death. It is
also possible that expression of large amounts of heterologous protein in cell culture led
to cell death due to the unnatural accumulation of protein. Therefore, the Drosophila
cell line could not be used for the study of in vivo peptide hormone processing under the
conditions employed.

Glutaminyl Cyclase activity of Drosophila QC and Drosophila QC-like proteins
Glutaminyl cyclase (QC) is a post-translational processing enzyme necessary for
the conversion of N-terminal glutamine to pyroglutamic acid in various peptides.
Published studies thus far have identified QC in various organisms from humans to yeast
with highly conserved amino acid sequences and enzymatic function. However, these
studies had not identified QC activity in insects. A bacterial expression system was used
to express putative QCs from Drosophila for characterization. In the system both a
Drosophila QC and QC-LK protein were identified, expressed, and purified from cDNA
vectors with enzymatic activity. Biochemical characterization revealed both enzymes
were comparable to the previously expressed and purified human QC. These results were

independently obtained by Parker (Parker 2007; Parker 2008) and Schilling et al.
(Schilling 2007).
Table 7 demonstrates the characteristics of the dQC and dQC-LK proteins
determined experimentally compared to the previously identified and characterized
papaya QC and human QC. These results indicated the QCs were glutaminyl cyclases
due to the similarities between all the QCs. Both Drosophila QCs were similar in size,
pH activity optima, and Km values. The Drosophila QCs appear to be more similar to
the mammalian QC due to the imidazole inhibition observed and the reactivity to
mammalian QC antibodies.

Table 7: Summary of QC Characteristics from purified C. papaya QC,
human QC-GST construct, Drosophila QC and Drosophila QC-LK.
Molecular weight (kDa)
pH activity optimum
Km (mM)
Gln-NH2
Gln-tBE
Inhibited by imidazole
Antibody reactivity
hQC polyclonal
peptide antibody

C. papaya QC
33
8.0

hQC-GST
68
7.5

Drosophila QC
44
7.5

Drosophila QC-LK
50
7.5

1.95
N/A
No

1.5
N/A
Yes

1.4
6.6
Yes

N/A
N/A
Yes

No
No

Yes
Yes

Yes
No

No
Yes

The values obtained experimentally for the Drosophila QC and QC-LK proteins
correlate well to the published data for the same proteins by Schilling et. al. (Schilling
2008) Expressed proteins in both laboratories revealed virtually identical enzymatic
properties. Data from both groups revealed the protein corresponding to the expressed
dQC protein had the most catalytic activity and was most similar enzymatically to the
human and other mammalian QCs. The kinetic data shown for the Drosophila QC and

QC-LK also correlates to the kinetic data published for the same proteins though the Km
values obtained were about 25% higher in our laboratory. The group observed the same
low catalytic efficiency observed for the expressed dQC and dQC-LK further validating
the results obtained. Both laboratories revealed the Drosophila QCs were inhibited by
imidazole derivatives with the same Ki values for commonly used QC inhibitors within
the experimental error.
The Drosophila QC and QC-LK protein sequences were verified through specific
sequence analyses using in-gel trypsin digest and MALDI-TOF. MALDI spectra resulted
in a mass list corresponding to the predicted Drosophila QC sequence with a likelihood
of greater than 70% for dQC and dQC-LK recombinant proteins. This proves the
expressed proteins do correspond to the protein sequences predicted from the Drosophila
cDNA vectors.
Computer analyses of the putative Drosophila QC sequence revealed various
physical properties of the proteins. Table 8 provides a comparison of these predictions
along with the published physical properties of human QC. The calculated molecular
weight of Drosophila QC is 41 kD and 38 kD for Drosophila QC-LK. Both values are
very similar to the molecular weight of 41 kD for the human QC sequence. The
theoretical pi of 6.3 for Drosophila QC and 6.8 for Drosophila QC-LK is also very
similar to 6.1, the pi of human QC.
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Table 8: Predicted properties of human QC, Drosophila QC, and Drosophila
QC-LK proteins.
Enzyme Property
Molecular weight
Pi
Glycosylation sites
Disulfide bonds
Subcellular
localization

Human QC
41 kD
6.1
N49; N296
C139-C164
Secretory pathway
signal

Drosophila QC
41 kD
6.3
N43
C136-C158
Mitochondrial signal

Drosophila QC-LK
38 kD
6.8
N157
C113-C137
Secretory pathway
signal

Subcellular localization predictions suggest the two Drosophila QC isoforms may
exhibit different subcellular localizations due to differences in the signal sequences. The
Drosophila QC-LK protein signal sequence predicts a secretory pathway localization
which is predicted as well as observed for the human QC. However, the DNA sequence
of the Drosophila QC protein has two potential signal sequences which arise from
alternative splicing events. One potential signal has a predictable mitochondrial
subcellular localization a significant threshold score. The other potential signal has a
predictable secretory subcellular localization; however, the threshold score was rather
low.
3-D structural comparisons showed the predicted 3-D structures of Drosophila
QC and Drosophila QC-LK were very similar to the published crystal structure of human
QC (figures 37 and 39). This further confirms the inclusion of the expressed Drosophila
QC and QC-LK into the family of known mammalian QC enzymes. The core of the
proteins, including the secondary structure, superimposes well with only the loop regions
showing differences. These results were confirmed by Schilling et. al. through the use of
circular dichroism. Analysis of the active site residues revealed not only the conservation

of known binding and/or catalytic residues, but also the conservation of the location of
important residues within the 3-D structure. The Drosophila QC and QC-LK predicted
structures also appear to contain a pocket for zinc in a similar location as the human QC.
Schilling et. al. revealed the Drosophila QC proteins do contain one zinc per catalytic
unit as predicted with the structures. Figures 38 and 40 demonstrate this active site
region with residues labeled.
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Figure 39: Predicted 3-D Structure of dQC-LK. Predicted 3-D structure of
Drosophila QC-LK (purple) compared to the crystal structure of human QC (blue).
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Figure 40: dQC-LK Predicted Active Site Residues. Active site comparison of
predicted three-dimensional structure of Drosophila QC-LK (purple) compared to the
crystal structure of human QC (blue). Left panel contains labels of important active site
residues verified by the hQC crystal structure and mutagenesis studies. (Huang, Liu et al.
2005)
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Prediction programs (iPSORT) demonstrated a probability of similar sites of Nlinked glycosylation among the putative Drosophila QCs and human QC. Human QC is
known to be glycosylated at asparagine 49 and asparagine 296. (Booth 2003) These
amino acids do not appear to be conserved in sequence alignments. Prediction programs
suggest possible N-glycosylation sites at N43 and N57 in the dQC sequence.
Comparison of the dQC predicted tertiary structure to the hQC crystal structure reveals
the N43 is in the same location relative to the N49 of hQC.

Similarly, N42 and Nl 57

are predicted as possible N-linked glycosylation sites in dQC-LK. However, only the
N157 of dQC-LK is located in the same area of the protein to an N-linked glycosylation
site of hQC in the tertiary structure comparisons. There is not a possible N-linked
glycosylation site corresponding to the N296 site in the hQC for either Drosophila QC.
The fact that both N43 of dQC and N157 of dQC-LK are located in the same area of the
proteins as the N49 of hQC, along with the glycosylation prediction programs, suggests
these are the best candidates for N-linked glycosylation. The location of the predicted
glycosylation sites for dQC and dQC-LK are shown in figures 41 and 42 compared to the
human crystal structure. Immunocytochemistry of whole Drosophila lystates revealed a
single, high molecular weight band suggesting post-translational modification of the in
vivo Drosophila QCs. This provides some experimental evidence to the presence of
glycosylated asparagine residues.
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Figure 41: Comparison of hQC and dQC glycosylation sites. The figure to the
left demonstrates the location of glycosylation sites of hQC, N49 and N296, along with
the predicted glycosylation site, N43 of dQC. The human mainchain is shown in black
and the Drosophila mainchain is shown in yellow. Human sidechains are shown in blue
and Drosophila sidechains are shown in pink.
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Figure 42: Comparison of hQC and dQC-LK glycosylation sites. The figure to
the left demonstrates the location of glycosylation sites of hQC, N49 and N296, along
with the predicted glycosylation site, N157 of dQC-LK. The human mainchain is shown
in black and the Drosophila-like mainchain is shown in green. Human sidechains are
shown in blue and Drosophila-Yyke sidchains are shown in purple.

The human QC contains a disulfide bond between residues CI39 and CI64.
(Schilling 2002) The predicted structure of the Drosophila QC and QC-LK does contain
cysteine residues in the same location and very similar orientations suggesting the
disulfide bond is conserved among speices. (figure 43) The cysteine residues conserved
in Drosophila QC are CI 36 and CI 58. The predicted structure of the Drosophila QC-LK
also contains two conserved cysteine residues, CI 13 and CI37, suggesting the
conservation of the disulfide bond. An overlay of the tertiary structure of hQC, dQC,
and dQC-LK are shown in figure 42 with the conserved cysteine residues highlighted.

Ill

Figure 43: Comparison of hQC and dQC isoforms disulfide bonds. This
image to the demonstrates the location of the hQC and predicted dQC and dQC-LK
disulfide bonds within the tertiary structure of the protein. The human mainchain is
shown in black, the Drosophila mainchain in yellow, and the Drosophila-Wks mainchain
in green. Human sidechains are shown in blue, Drosophila in pink, and Drosophila-\\ke
in purple. The orientation of the disulfide bond is shown in orange.

The predicted conservation of the glycosylation sites and disulfide bonds further
validates the predicted tertiary structures constructed for the Drosophila QCs. The
identical location of the cysteine residues, as well as the similar locations of glycosylated
asparagine residues, suggests the predicted structures reveal clues to the conservation of
enzyme structure. The conservation of these sites helps reveal the evolutionary
relationship among the Drosophila QCs and other mammalian QCs, which will be further
discussed.
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Location and expression levels of Glutaminyl cyclase in Drosophila
High throughput RNA in situ databanks indicated a high expression of the dQCLK in early embryonic stages from maternal influence and in the embryonic hypopharynx
during later embryonic stages. In constrast, microarray data indicated high levels of
mRNA in the male and female sexual organs, the head, and the crop. However, no RNA
in situ or microarray data was available in the database for the dQC gene. Therefore, in a
better attempt to understand the overall function and purpose for two distinct Drosophila
QCs, the location and expression levels of dQC and dQC-LK were investigated using
RNA in situ methods and immunocytochemistry.
Both the dQC and dQC-LK RNA transcripts were identified in the early embryo
via maternal transcripts as well as some epidermal and mesodermal tissues. However, a
high expression level of the dQC-LK transcript was observed in the developing nerve
cord suggesting the importance of the dQC-LK in early embryonic nerve cord and
neuropeptide development. Location of the dQC-LK transcript appears in the midline of
the nerve cord localized within segment polarity stripes. The unpatterned staining of the
nerve cord suggests a vesicular pattern for the expression. Figure 44 compares the
staining observed in the developing nerve cord with the dQC-LK RNA probe to a stain of
a typical neuronal pattern. The lack of a repeating pattern in the dQC-LK staining
demonstrates the dQC-LK is not located in an organized neuronal pattern, but instead
likely near the secretory vesicles randomly located throughout the nerve cord. Typically
localized pools of mRNA transcripts are generated far away from the cell body and
especially, in the CNS, pooled in the synapses to produce localized protein on demand. It
is possible the dQC-LK mRNA may not be in the vesicles, but located near vesicle^
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within a budding synapse. This would make the mRNA pattern appear vesicular. The
non-patterned staining of the nervous tissues has been observed in RNA in situ studies
with other Drosophila post-translational processing enzymes. RNA in situ and
immunocytochemistry studies of the Drosophila PHM and PAL proteins, proteins which
together form the bifunctional PAM homolog, demonstrated a non-patterned staining in
the larval CNS. This was further demonstrated to mirror the pattern observed with
immunocytochemistry of various neuropeptides and peptide hormones in Drosophila.
(Kohlekar 1997) Therefore, the non-patterned staining observed in the Drosophila nerve
cord with the dQC-LK RNA in situ could also mirror the non-patterned staining observed
in peptides which require the post-translational modification. Also, the localization of the
dQC-LK mRNA to the neuronal system into secretory vesiclular region is similar to the
localization of the mammalian QC into secretory vesicles of the nervous tissues as
observed in published mammalian QC localization studies. (Pohl 1991) (Bockers 1995)

Figure 44: Nerve cord staining. The figure to the left demonstrates segments of
a dissected nerve cord developed with the dQC-LK RNA probes. The image to the right
demonstrates a typical staining of a neuronal expression pattern. (Leal, S., unpublished
data)
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Though the RNA in situ analyses did localize the dQC-LK to the hypopharynx as
previously described in the database studies, various other tissues were also identified.
This could be due to the probe type used. For analyses, total transcript length probes
were utilized. This allows all transcripts produced, even in the event of alternative
splicing, to be identified. No information was available to determination the length of
probes used in the database studies.
Localization studies suggest the dQC-LK is expressed at a higher level than the
dQC-LK throughout embryonic development. Equal amounts of probe were added
during experimental procedures resulting in comparable data. The lack of staining in the
dQC embryos demonstrates the dQC is not expressed at a high level and that the dQC-LK
is the dominant isoform expressed in Drosophila during embryonic development.
Immunocytochemistry revealed only slight staining in the hypopharynx region.
Low levels of staining could indicate either expression within only the early developing
hypopharynx or low antibody specificity within the organism as compared to
recombinant protein. Further investigation would require production of Drosophila QC
specific antibodies. The results observed with the polyclonal antibody demonstrated a
granular staining pattern. Similar results were obtained in the immunocytochemistry
study of the Drosophila PAM homologs, dPALl and dPAL2. The dPALl homolog
demonstrated a granular staining pattern as well. (Han 2004) This result could provide
some clues into the subcellular distribution of the dQC protein suggesting the dQC
protein is a intracellular protein and not secreted.
Published localization studies of other Drosophila secretory pathway processing
enzymes revealed similar results. The Drosophila PAM homologs, dPALl and dPAL2,
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were localized within the endoplasmic recticulum and within developing neurons.
Similar to the localization of dQC-LK observed by RNA in situ, dPAL2 was distributed
randomly throughout neuronal processing. This indicates the dQC-LK and dPAL2 are
located within similar regions aiding the confirmation of the results obtained from
Drosophila in situ hybridization studies. The similar locations suggest the dQC-LK and
dPAL2 serve similar functions in the Drosophila. (Han 2004)

Biological Role of Glutaminyl Cyclase-like proteins
The identification of another QC in the Drosophila genome was followed by the
identification of QC-LK proteins in many other species including humans. As in
Drosophila, the human QC-LK is not the result of a gene duplication event. The genes
are located on different chromosomes. Therefore, an attempt to explain the presence of
QC-LK proteins would need to address its presence in various species.
Localization studies suggest the two different isoforms are located within
different areas in Drosophila. Therefore, we believe the presence of two isoforms may
be necessary for the proper pGlu formation in the whole fly for various peptides. Various
neuropeptides require the activity of QC to produce the pGlu residue. The presence of
dQC-LK in the developing nerve cord could serve this function. Peptides other than
neuropeptides may use the dQC for proper pGlu formation.
Schilling et. al. suggested the presence of one Drosophila QC isoform,
corresponding to the dQC in our studies, in the mitochondria due to signal sequence
predictions, subcellular distribution of enzyme activity, and double-staining experiments.
They demonstrated the dQC was co-localized with the mitochondria and activity was
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present in the cell debris and heavy membrane fraction. The isoform corresponding to
dQC-LK in our studies demonstrated activity in the cell culture media, suggesting the
enzyme is secreted. Other evidence for the subcellular localization of the dQC protein
include the granular immunocytochemical staining we observed.
There are mitochondria peptides which contain an N-terminal pyroglutamic acid
residue. Other than the secretory pathway peptides containing an N-terminal pGlu
residue such as adipokinetic hormone and coazonin, there are several peptides containing
N-terminal sequences signaling transport into the Drosophila mitochondria that contain
an N-terminal pGlu residue. Proteins such as acyl-CoA dehydrogenase and succinate
dehydrogenase, contain an N-terminal signal sequence which allows the peptides to be
transported into the mitochondria. (Schilling 2007) Once past the mitochondrial lumen,
the signal sequence is cleaved and an N-terminal pGlu residue is observed. This could
suggest a mitochondrial QC is required for proper protein maturation. dQC detected in
low levels in the Drosophila embryos could function as the mitochondrial QC and
possibly not be capable of any specified staining. However, it is likely that the
pyroglutamate modification occurs outside the mitochondria prior to the protein's
entrance.
We have also hypothesized that the two isoforms are required for activity in both
the regulated secretive and constitutive secretive pathways. Various known
neuropeptides have been localized to the regulated secretive pathway which require an Nterminal pGlu residue for proper maturation. However, other proteins known to use the
constitutive pathway also require N-terminal pGlu suggesting the requirement for a
glutaminyl cyclase in this pathway as well. For example, ranpiranse (onconase®), a
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ribonuclease enzyme originally isolated from frog oocytes which has been proposed for
cancer treatment, contains an N-terminal pGlu residue. Onconase matures through the
constitutive pathway and requires an N-terminal pGlu residue for toxicity.
Immunocytochemistry revealed a single, higher molecular weight band in the
Drosophila whole fly lysate suggesting possible post-translational modifications of the
Drosophila QC proteins in vivo. Computer analysis led to the identification of
differential phosphorylation sites in the dQC and dQC-LK proteins suggesting the two
isoforms could also be under phosphorylation dependent regulation. Therefore, the two
isoforms would be necessary for activity during different cellular conditions. Prediction
programs suggested 20 tyrosine phosphorylation sites, 60 serine phosphorylation sites,
and 5 threonine phosphorylation sites on dQC as opposed to 3 tyrosine phophorylation
sites, 7 serine phosphorylation sites, and 3 threonine phosphorylation sites predicted on
dQC-LK. Therefore, differential regulation could lead to the activation of a specific
iso form during specific cellular events resulting in a need for two different QC isoforms.

Location and expression levels of glutaminyl cyclase in mammals
Analysis of the location and expression levels of QC in mammals utilized
commercial mouse tissue blots. Previous localization information crudely localized
mammalian QC to secretory granules in cow tissue. (Bockers 1995) A bovine tissue
distribution study demonstrated QC was abundant in brain and pituitary. (Sykes 1999)
However, no localization for mouse was previously evaluated. The mouse tissue blots
indicated expression of QC in all tissues tested when both the commercial polyclonal and
purified peptide antibody were used. Highest expression levels were identified in fetus,
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eye, skin, and adrenal glands in descending order though levels were detected in all
tissues examined. These preliminary results indicate the QC is an important enzyme in
widely varying cellular locations.
The high level expression of mouse QC in the fetus suggests QC may be very
important during the early development stages of the mouse. This finding would agree
with the finding that a Drosophila QC isoform is highly expressed at high levels in areas
such as the nervous system, during the early development.
Comparison of the results obtained from the tissue blot also correlate well to the
Northern blot analysis of bovine QC presented by Pohl et al. Other than the high levels
of QC identified in the brain and pituitary, QC was observed in various other tissue types
including heart and skeletal muscle. (Pohl 1991) Further analyses and conclusions
would require differentiation between the two QC isoforms also found in mice through
production of mouse isoform specific antibodies.

Are Glutaminyl Cyclase and Aminopeptidase promiscuous enzymes?
Promiscuous enzymes catalyze two different, though often related, enzymatic
reactions utilizing the same active site. Due to the tertiary structure and active site
similarities of human QC and bacterial zinc aminopeptidase, along with the similarity of
enzymatic reaction catalyzed, the possibility of QC and aminopeptidase acting as
promiscuous enzymes was hypothesized. Our results demonstrated the ability of both
human and Drosophila QC to cleave N-terminal amino acids from a typical leucine
aminopeptidase substrate, hence, demonstrating aminopeptidase activity.
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Due to the observed aminopeptidase activity of QC on the leucine substrates, it
was hypothesized that QC must have the ability to bind leucine. Therefore, the use of
leucine derivatives as inhibitors was explored. In the presence of tested leucine
derivatives including leu-NH2, leu-gly, leu-ala, leu-leu, leupNA, and leucine
chloromethyl ketone, a decrease in QC activity was observed. Decrease in activity in the
presence of leu-peptide analyzed graphically suggests the substrates were binding in a
competitive manner. Therefore, the leucine peptides were capable of binding the QC
active site.
The Aeromonas proteolytic** aminopeptidase (AAP) most efficiently cleaves
leucine also demonstrating a high affinity for this amino acid. The aminopeptidase
reaction mechanism first requires the amino acids C-terminal to the leucine residue to
bind to the SI pocket. The SI pocket is a hydrophobic pocket formed by two cysteines,
C223 and C227, along with Ml 80, F244, and Y251. Next the carbonyl group binds the
zinc 1, which is the zinc that corresponds to the zinc found in QC. Next the N-terminal
amide group interacts with zinc 2. However, experimental data has demonstrated the
aminopeptidase is over 80% active with the loss of zinc 2 suggesting the neighboring Asp
117 or Asp 179 can act as the amide binding groups. Formation of the intermediate
initiates the Glu 151 to act as a nucleophile, or general base, resulting in the dissociation
of the carbonyl group. The zinc 1, now bound Glu 151, attacks the carbonyl group
forming the tetrahedral intermediate. Finally Glu 151 donates a proton and allows the
amide group to form the leaving group. (Lowther 2002) The active site amino acids are
shown in figure 45.
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Figure 45: Aeromonas aminopeptidase active site residues. Structure of
Aeromonas aminopeptidase active site bound to leucine phosphonic acid. Amino acids
are shown in blue, inhibitor in pink, and zinc metals in gray.

Comparison of the AAP and hQC active sites provide some evidence for the
ability of QC to specifically bind to a leucine peptide. The 3-D structure demonstrates
the two active sites are virtually identical with conservation of all catalytic residues as
demonstrated in figure 46. The absence of zinc 2 in the QC structure is mechanistically

compensated by the presence of a conserved aspartate residue, Asp 248, which
corresponds to Asp 179 of the aminopeptidase capable of performing the zinc 2 catalytic
function.

Figure 46: Aeromonas aminopeptidase active site hQC overlay. This figure
demonstrates the conservation of 3-D structure of all aminopeptidase active site residues
in the hQC crystal structure. AAP is shown in yellow with labels in green and hQC is
shown in blue with labels in red.

The ability of the leucine chloromethyl ketone to act as an affinity label with the
mammalian family QCs is due to the slight alteration of the enzyme active site. All
chloromethyl ketones react with free active site histidine residues. In the AAP active site
the His 97 reacts with the second zinc and is therefore unable to react with the ketone.
This explains the reversible inhibition observed by leucine chloromethyl ketone with
AAP. The loss of the second zinc in the human QC active site would allow the
corresponding histidine, His 140, to freely react with the chloromethyl ketone. This
explains the irreversible inhibition observed with human QC in the presence of leucine
chloromethyl ketone.
The most observable variation in the two 3-D structures of the AAP and hQC lies
in the S-pocket. As demonstrated by Huang et. al. in the development of the hQC crystal
structures, the substitution of Phe 244 in hQC results in loss of the S-pocket, a
hydrophobic pocket responsible for interacting with the C-terminal portion of the peptide
cleaved by the aminopeptidase. Therefore, only the N-terminal residue has access to the
hQC active site as opposed to the aminopeptidase which binds a larger portion of the
peptide destined for cleavage. However, this change does not affect the normal
enzymatic activity of either enzyme because the two enzymes bind their natural
substrates in a different manner. The normal binding of hQC to a glutamine peptide and
AAP to a leucine peptide is shown in figure 47. The hQC binds the glutamine in the
active site with the C-termnial portion of the protein not interacting with any of the amino
acids displayed in the region. However, the AAP binds the leucine in the active site with
the C-terminal portion of the protein interacting with the amino acids displayed. These
amino acids make up the S-pocket.
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Figure 47: Comparison of AAP and hQC Active Site Binding Orientations.
The top image displays the orientation of a peptide binding both the hQC (to the left) and
AAP (to the right). (Huang 2005) The bottom image displays a schematic drawing. The
arrow in the bottom images demonstrates the orientation of the peptide bound to the
enzymes with the the N-terminal amino acid listed. This figure demonstrates the hQC
binds only the N-terminal glutamine residue with the C-terminus extending outward.

The small leucine peptides ability to bind the QC as inhibitors is possible due to
the small size of the leucine peptides. Only the leucine residue must bind the conserved
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active site residues demonstrated in the active site overlay. Therefore, loss of the Spocket does not affect the binding of inhibitors. In a similar manner the low levels of
aminopeptidase activity in the QCs tested are also conceivably due to the type of
aminopeptidase substrate used. The aminopeptidase substrates were single leucine amino
acids coupled to a p-nitroanilide. Figure 48 demonstrates the binding of the leucine
inhibitor to AAP. The leucine destined for cleavage does not interact with the S-pocket.
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Figure 48: Space filling model Aeromonas aminopeptidase S-pocket. This
image demonstrates the S-pocket formed in the AAP for binding of the C-terminal
peptide chain in aminopeptidase reactions.

The lack of the S-pocket suggests the human QC would not be able to bind long
peptides in the same manner as the AAP. This would provide some insight into the
aminopeptidase ability of QC in vivo. Without the hydrophobic S-pocket to bind the Cterminal portion of the protein destined for N-terminal amino acid cleavage, QC would
not be able to complete aminopeptidase reactions in vivo.

Evolution of Glutaminyl Cyclase
Evolution of the animal QC enzyme family appears to be linked to the evolution
of the aminopeptidase enzyme family due to similarity in catalytic reaction and tertiary
structure. The ability of QC to catalyze an aminopeptidase reaction and bind leucine
substrates further demonstrates the relationship between the two enzyme families. These
conclusions suggest a divergent evolution in which two closely related enzyme families
have a common evolutionary origin but have diverged over time to develop specific
functions within the organism.
To further analyze the relationships among the various QCs, development of
phlyogenetic trees (figure 49) based on a comparison of the tertiary structures of plant,
bacterial, and animal QCs, along with various aminopeptidases, were completed. As
evident from the tree, the human QC is more closely related to the bacterial and some
leucine aminopeptidases than to the plant QC. The close evolutionary relationship
theorized further explains the aminopeptidase activity and leucine binding ability of the
mammalian QCs. The plant and bacterial QCs appear to have the most distant
phylogenetic relationship when compared to the bacterial aminopeptidases and other
QCs.

1: human
2: sheep
3: chicken
4: pig
5: rat
6: mouse
7: cow
8: chimp
9: frog
10: bullfrog
11: dog
12: mosquito
13: Drosophila QC
14: Drosophila
QC-LK
15: Aeromonas AP
16: human leuAP
17: bacterial QC
18:cowleuAP
19: plant leuAP
20: papaya QC

T
Figure 49: Tertiary structure based neighbor-joining phylogentic tree. This
tree demonstrates the relationship of various QCs to the AP protein family due to tertiary
structure similarity. Number 1 represents human QC. Numbers 2 - 1 4 represent various
QCs from yeast to mammals. Numbers 1 5 - 1 9 represent various aminopeptidases.
Number 20 represents papaya QC.
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Final Conclusions
Experimental work, along with the phylogenetic tree analysis, has led to the
conclusion that the animal QC family and bacterial aminopeptidases represent an instance
of divergent evolution. The use of same catalytic residues, location of zinc in the active
site, tertiary structure similarity, active site binding of leucine, and AP activity of QC all
suggest the two enzymes evolved from a common ancestor. However, the animal QC
family and plant QC family represent an instance of convergent evolution. Due to the
very different tertiary structure, active site residues, and location of zinc in structure
suggest the two evolved from a different ancestor to have the same function.
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